US20010029660A1 - Stent drug delivery system - Google Patents
Stent drug delivery system Download PDFInfo
- Publication number
- US20010029660A1 US20010029660A1 US09/880,615 US88061501A US2001029660A1 US 20010029660 A1 US20010029660 A1 US 20010029660A1 US 88061501 A US88061501 A US 88061501A US 2001029660 A1 US2001029660 A1 US 2001029660A1
- Authority
- US
- United States
- Prior art keywords
- stent
- powdered
- metals
- metal
- preform
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/048—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/146—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
- B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
- B23K26/00—Working by laser beam, e.g. welding, cutting or boring
- B23K26/36—Removing material
- B23K26/40—Removing material taking account of the properties of the material involved
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L27/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Compositions of derivatives of such polymers
- C08L27/02—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Compositions of derivatives of such polymers not modified by chemical after-treatment
- C08L27/12—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Compositions of derivatives of such polymers not modified by chemical after-treatment containing fluorine atoms
- C08L27/18—Homopolymers or copolymers or tetrafluoroethene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/88—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/92—Stents in the form of a rolled-up sheet expanding after insertion into the vessel, e.g. with a spiral shape in cross-section
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
- A61L2300/608—Coatings having two or more layers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
- B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
- B23K2103/00—Materials to be soldered, welded or cut
- B23K2103/02—Iron or ferrous alloys
- B23K2103/04—Steel or steel alloys
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
- B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
- B23K2103/00—Materials to be soldered, welded or cut
- B23K2103/02—Iron or ferrous alloys
- B23K2103/04—Steel or steel alloys
- B23K2103/05—Stainless steel
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
- B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
- B23K2103/00—Materials to be soldered, welded or cut
- B23K2103/08—Non-ferrous metals or alloys
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
- B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
- B23K2103/00—Materials to be soldered, welded or cut
- B23K2103/08—Non-ferrous metals or alloys
- B23K2103/14—Titanium or alloys thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
- B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
- B23K2103/00—Materials to be soldered, welded or cut
- B23K2103/18—Dissimilar materials
- B23K2103/26—Alloys of Nickel and Cobalt and Chromium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
- B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
- B23K2103/00—Materials to be soldered, welded or cut
- B23K2103/30—Organic material
- B23K2103/42—Plastics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
- B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
- B23K2103/00—Materials to be soldered, welded or cut
- B23K2103/50—Inorganic material, e.g. metals, not provided for in B23K2103/02 – B23K2103/26
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49995—Shaping one-piece blank by removing material
Definitions
- This invention relates to stents for maintaining the patency of body passages. Additionally, the stents may serve as drug delivery vehicles.
- the invention has particular application to stenting in blood vessels of the human body and will be described with reference thereto. However, in a broader sense it relates to stenting in any body passage, including such passages as the gastrointestinal tract, urethral and ureteral tracts, bronchial and esophageal tracts.
- the invention also has particular reference to stents comprising compounds useful for the treatment and prevention of restenosis and also will find application in dilating and maintaining the patency of various body passages such as ureters and the like.
- a porous stent made from a powdered metal or polymeric material is disclosed.
- the inventive stent is an expandable intraluminal stent comprising a main body portion having a first end, a second end and a flow passage defined therethrough, the main body portion being sized for intraluminal placement within a body passage and subsequent expansion for implantation.
- the main body portion of the stent of the present invention is further characterized in that it is formed at least in part of at least one porous material, the porous material having been formed from a powdered metal or polymeric material.
- a drug is contained within the pores of the stent for delivery to the body.
- the stent may be coated with a drug.
- the stent is comprised of at least two porous metals.
- the present invention is also directed to a method for making a porous expandable intraluminal stent comprising the steps of providing a powdered material, subjecting the powdered material to high pressure to form a compact, sintering the compact to form a final porous material and forming a stent from the porous material.
- at least one drug is loaded into the pores of the stent.
- FIG. 1 a is a perspective view of one embodiment of a stent according to the present invention.
- FIG. 1 b is an enlargement of a portion of FIG. 1 a showing pores on the surface of the metal.
- FIG. 2 is a sectional view of another embodiment of a stent in accordance with this invention.
- FIG. 3 is a perspective view of another embodiment of a stent according to the present invention.
- FIG. 4 a is a plan view development of the inventive stent in sheet form prior to rolling.
- FIG. 4 b is a sectional view of another embodiment of a stent according to the present invention.
- FIG. 5 is a perspective view of yet another embodiment of a stent according to this invention.
- the present invention relates to a porous stent made from a powdered material such as powdered metal or polymer for maintaining the patency of body passages.
- Stents to which the present invention relates may be either balloon expandable or self-expanding as well as springy in form.
- self-expanding stents are known which are braided, woven or mesh-like in structure, although many other types of self-expanding stents including solid stents are also known.
- Such stents have memory characteristics and, if distorted in length and/or diameter by external forces, they will return or tend to return to a preformed configuration upon the release of external forces.
- Balloon expandable stents may be expanded by the application of a suitable amount of force to the stent.
- the stents of the present invention may be used to deliver drugs to a desired bodily location.
- drug denotes any compound which has a desired pharmacologic effect, or which is used for diagnostic purposes.
- Useful drugs in the context of the present invention include, but are not limited to angiogenic drugs, smooth muscle cell inhibitors, collagen inhibitors, vasodilators, anti-platelet substances, anti-thrombotic substances, anti-coagulants, cholesterol reducing agents and combinations thereof.
- the drugs may include radiochemicals to irradiate and/or prohibit tissue growth or to permit diagnostic imaging of a site.
- the porous stent may be used as a drug-delivery system to, for example, prevent restenosis.
- the drugs may include radiochemicals to irradiate and prohibit tissue growth.
- Angioplasty and stent deployment may cause injury of the endothelial cell layer of blood vessels, causing smooth muscle cell proliferation, leading to restenosis.
- smooth muscle cell proliferation To control smooth muscle cell growth endothelialization of cells on the inner wall surface of vessels will prevent or prohibit the smooth muscle growth.
- human growth factors may be included in the outer layer and delivered.
- the stent of the present invention may be formed of any bio-compatible powdered metals such as stainless steel. Powdered metals typically are available in powder sizes as small as 40 microns or less. While powdered metals of any powder size may be used in forming the stents of the present invention, preferably powders 40 microns or less will be used in forming the porous metal stent of the present invention. More preferably, powdered metals ranging in size from 6 to 12 microns will be used. Especially desirable are powders with good flow properties so that the particles may be dispensed easily into a die cavity for metal processing.
- Suitable metals include, but are not limited to, spring steel, nitinol and titanium as well as any other bio-compatible metal which may become available in powdered form in the future. Suitable metals do not produce toxic reactions or act as carcinogens.
- the stent of the present invention may also be formed of bio-compatible powdered polymeric materials such as PTFE.
- the stents of the present invention may also be prepared with different mean pore sizes. Pore size is an important parameter in that certain macromolecular drugs may be excluded from use where the pore size is very small. The pore size may also play a role in determining the extent of cellular infiltration or tissue ingrowth during implantation of the stent. While cellular ingrowth is sometimes desirable, it can also lead to complications such as infection and difficulty in removing the stent. Stents with a mean pore size of greater than about 10 microns can allow infiltration of cellular sized biomaterials; stents with mean pore sizes in the range of 1-10 microns may accommodate infiltration of some of the above bio-materials.
- Stents with pore sizes less than about 1 micron will not generally accommodate infiltration of any of the above biomaterials but can accommodate infiltration of macromolecular and small biomaterials.
- the pore size of the stent may be varied to foster or inhibit cellular infiltration and/or tissue ingrowth.
- the pore size may also be varied to facilitate delivery of drugs of different molecular sizes.
- the material processing proceeds with a pressure treatment step in which the powdered material in a die cavity is subjected to pressures of up to twenty tons or more. At such high pressures, the powder begins to interlock, forming a compact with pockets of air remaining in the metal.
- the pressure treatment step usually proceeds at room temperature although warm or hot pressing may be used. Other techniques to form the compact, as known in the art, may be substituted for the pressure treatment step.
- the die cavity used in this step may be a stent die cavity to allow for direct casting of the stent or alternatively, may be for some other form such as a tube or a sheet. Following the pressure treatment step, the compact has sufficient strength to allow for routine handling without breakage.
- the compact After ejection from the die, the compact is sintered to form a coherent metal or polymer mass in the shape of the die.
- the pressure treatment step can be eliminated and the processing limited to a sintering in which the metal or polymer powder is heated in a die resulting in a low density, highly porous compound.
- the sintering step may actually partially melt the metal or polymer as in liquid-phase sintering, in the preferred embodiment, the sintering step does not melt the metal or polymer as the temperature is maintained below the melting point of elemental metal or any alloys that have formed or the polymer melting point.
- the sintered metal or polymer will exhibit a porosity ranging from less than 10 percent to about 80 percent of the total volume. The percentage porosity is a measure of the void space within the metal.
- FIGS. 1 a and 1 b illustrate one such stent 10 , with pores 14 formed by laser cutting apertures 18 in a sheet of porous metal.
- FIG. 2 illustrates a stent 20 which is composed of a number of interconnected members 22 , the members and interconnections 24 made of a metal containing pores 26 .
- a braided stent may be formed of a series of strands arranged in a crossing configuration which may be woven, braided or the like.
- the strands of porous metal or polymer can be deformed so to provide a reduced diameter of the stent which facilitates its delivery to the targeted portion of a vessel or other passageway and once disposed at the target portion the stent can then be allowed to expand to its preformed configuration and larger diameter.
- the stents of the present invention may be prepared in a range of porosities allowing for the production of stents with differing drug delivery characteristics.
- the porosity may be between twenty and eighty percent of the total volume and more suitably between forty and sixty percent of the volume.
- the stent may be impregnated with one or more drugs by any known process in the art including high pressure loading in which the stent is placed in a bath of the desired drug or drugs and subjected to high pressure or, alternatively, subjected to a vacuum.
- the drug may be carried in a volatile or non-volatile solution.
- the volatile carrier solution may be volatilized.
- the vacuum the air in the pores of the metal stent is evacuated and replaced by the drug-containing solution.
- the stent may further be coated with one or more layers of one or more drugs to allow for longer term drug elution optionally employing a number of different drugs over time.
- the drug in the pores would not be eluted until the coating of drug has been absorbed, thereby allowing for longer term drug treatment than would be available from the coated metal alone.
- FIG. 3 shows a coil stent 30 in which the porous metal stent 30 further comprises such a coating 32 (the pores have been omitted for clarity).
- the inventive stent may also be formed from a rolled up flat sheet comprised of a porous metal or polymer as shown in FIG. 4 a .
- the sheet 35 contains a plurality of apertures 36 and pores 38 as well as tabs 37 .
- the tabs are inserted into the holes 36 a - c when the stent is rolled, as shown in FIG. 4 b .
- the stent may be rolled tightly for delivery and implantation and be self-expandable to the extent that it tends to unroll.
- the stent may further be laminated with a layer of drug over the porous surface of the stent. Otherwise, it may simply be expanded by independent expansion means such as a balloon catheter positioned inside the stent as is already known in the art.
- Another embodiment of the invention contemplates the fabrication of any stent design per se taken from the prior art, the stent prepared from a porous metal or polymer, the pores of the metal or polymer including one or more drugs.
- FIG. 5 depicts one such stent, 40 , the first metal 42 containing first pores 44 therein and the second metal 46 containing second pores 48 therein.
- one drug may be loaded into the pores of the first porous metal and a second drug loaded into the pores of the second porous metal.
- the same drug can be loaded into both the first and second porous metals.
- the present invention is also directed to a method for making a porous metal, expandable intraluminal stent comprising the steps of providing a powdered metal or polymeric material, subjecting the powder to high pressure to form a compact, sintering the compact to form a final porous metal or polymer, forming a stent from the porous metal and, optionally, loading at least one drug into the pores.
- the drug(s) may be loaded into the pores by placing the stent in a liquid bath comprising the at least one drug at high pressure, by placing the stent in a liquid bath within a chamber, the liquid bath comprising the drug(s), and reducing the pressure within the chamber below ambient pressure or by any other method known in the art.
- the invention is directed to a method of making an expandable intraluminal stent of varying porosity comprising the steps of providing two or more metal and/or polymeric powders in a die, subjecting the two or more powders to high pressure to form a compact, sintering the compact to form a final porous metal or polymer of varying porosity, forming a stent from the porous metal or polymer and, optionally, loading at least one drug into the pores.
- the two or more powdered metals and/or polymers can comprise at least two different metals and/or polymers or can comprise one metal or polymer, the one metal or polymer provided in at least two different average particle sizes or can comprise several different metals or polymers provided in several different average particle sizes.
- the porosity of the stent in different regions of the stent can be tailored by forming the stent of several different powdered metals or polymers comprising a combination of different elemental metals or alloys or polymers in powdered form, or using the same elemental metal, alloy or polymer but providing it in several powders of different average particle size or by some combination of different metals and/or polymers and same metals and/or polymers of different particle size.
Abstract
Expandable intraluminal stents are provided as well their method of manufacture. These stents are made of metal, the metal characterized by a desired porosity, with a drug compressed into the pores of the stent. The stents are formed by subjecting one or more powdered metals in a die cavity to a pressure treatment followed by a heat treatment. The metal may be cast directly in a stent-like form or cast into sheets or tubes from which the inventive stents are produced. The so-formed porous metal stent is then loaded with one or more drugs.
Description
- This application is a Continuation of U.S. application Ser. No. 08/940,696 filed Sep. 30, 1997, the contents of which are incorporated herein in their entirety by reference.
- This invention relates to stents for maintaining the patency of body passages. Additionally, the stents may serve as drug delivery vehicles. The invention has particular application to stenting in blood vessels of the human body and will be described with reference thereto. However, in a broader sense it relates to stenting in any body passage, including such passages as the gastrointestinal tract, urethral and ureteral tracts, bronchial and esophageal tracts. The invention also has particular reference to stents comprising compounds useful for the treatment and prevention of restenosis and also will find application in dilating and maintaining the patency of various body passages such as ureters and the like.
- In accordance with the present invention, a porous stent made from a powdered metal or polymeric material is disclosed. The inventive stent is an expandable intraluminal stent comprising a main body portion having a first end, a second end and a flow passage defined therethrough, the main body portion being sized for intraluminal placement within a body passage and subsequent expansion for implantation. The main body portion of the stent of the present invention is further characterized in that it is formed at least in part of at least one porous material, the porous material having been formed from a powdered metal or polymeric material.
- In another embodiment of the present invention, a drug is contained within the pores of the stent for delivery to the body.
- In another embodiment of the present invention, the stent may be coated with a drug.
- In another embodiment of the present invention, the stent is comprised of at least two porous metals.
- The present invention is also directed to a method for making a porous expandable intraluminal stent comprising the steps of providing a powdered material, subjecting the powdered material to high pressure to form a compact, sintering the compact to form a final porous material and forming a stent from the porous material. In another embodiment of the above-mentioned inventive method, at least one drug is loaded into the pores of the stent.
- FIG. 1a is a perspective view of one embodiment of a stent according to the present invention.
- FIG. 1b is an enlargement of a portion of FIG. 1 a showing pores on the surface of the metal.
- FIG. 2 is a sectional view of another embodiment of a stent in accordance with this invention.
- FIG. 3 is a perspective view of another embodiment of a stent according to the present invention.
- FIG. 4a is a plan view development of the inventive stent in sheet form prior to rolling.
- FIG. 4b is a sectional view of another embodiment of a stent according to the present invention.
- FIG. 5 is a perspective view of yet another embodiment of a stent according to this invention.
- The present invention relates to a porous stent made from a powdered material such as powdered metal or polymer for maintaining the patency of body passages. Stents to which the present invention relates may be either balloon expandable or self-expanding as well as springy in form. For example, self-expanding stents are known which are braided, woven or mesh-like in structure, although many other types of self-expanding stents including solid stents are also known. Such stents have memory characteristics and, if distorted in length and/or diameter by external forces, they will return or tend to return to a preformed configuration upon the release of external forces. This expansion may be due to the natural springiness of the stent, for instance with a rolled up sheet stent, or as a result of a phase transition occurring in the stent material. Balloon expandable stents may be expanded by the application of a suitable amount of force to the stent.
- The stents of the present invention may be used to deliver drugs to a desired bodily location. As used in this application, the term “drug” denotes any compound which has a desired pharmacologic effect, or which is used for diagnostic purposes. Useful drugs, in the context of the present invention include, but are not limited to angiogenic drugs, smooth muscle cell inhibitors, collagen inhibitors, vasodilators, anti-platelet substances, anti-thrombotic substances, anti-coagulants, cholesterol reducing agents and combinations thereof. The drugs may include radiochemicals to irradiate and/or prohibit tissue growth or to permit diagnostic imaging of a site.
- The porous stent may be used as a drug-delivery system to, for example, prevent restenosis. The drugs may include radiochemicals to irradiate and prohibit tissue growth. Angioplasty and stent deployment may cause injury of the endothelial cell layer of blood vessels, causing smooth muscle cell proliferation, leading to restenosis. To control smooth muscle cell growth endothelialization of cells on the inner wall surface of vessels will prevent or prohibit the smooth muscle growth. To promote endothelialization human growth factors may be included in the outer layer and delivered.
- The stent of the present invention may be formed of any bio-compatible powdered metals such as stainless steel. Powdered metals typically are available in powder sizes as small as 40 microns or less. While powdered metals of any powder size may be used in forming the stents of the present invention, preferably powders 40 microns or less will be used in forming the porous metal stent of the present invention. More preferably, powdered metals ranging in size from 6 to 12 microns will be used. Especially desirable are powders with good flow properties so that the particles may be dispensed easily into a die cavity for metal processing. Other suitable metals include, but are not limited to, spring steel, nitinol and titanium as well as any other bio-compatible metal which may become available in powdered form in the future. Suitable metals do not produce toxic reactions or act as carcinogens. The stent of the present invention may also be formed of bio-compatible powdered polymeric materials such as PTFE.
- The stents of the present invention may also be prepared with different mean pore sizes. Pore size is an important parameter in that certain macromolecular drugs may be excluded from use where the pore size is very small. The pore size may also play a role in determining the extent of cellular infiltration or tissue ingrowth during implantation of the stent. While cellular ingrowth is sometimes desirable, it can also lead to complications such as infection and difficulty in removing the stent. Stents with a mean pore size of greater than about 10 microns can allow infiltration of cellular sized biomaterials; stents with mean pore sizes in the range of 1-10 microns may accommodate infiltration of some of the above bio-materials. Stents with pore sizes less than about 1 micron will not generally accommodate infiltration of any of the above biomaterials but can accommodate infiltration of macromolecular and small biomaterials. Thus, the pore size of the stent may be varied to foster or inhibit cellular infiltration and/or tissue ingrowth. Of course, the pore size may also be varied to facilitate delivery of drugs of different molecular sizes.
- The material processing proceeds with a pressure treatment step in which the powdered material in a die cavity is subjected to pressures of up to twenty tons or more. At such high pressures, the powder begins to interlock, forming a compact with pockets of air remaining in the metal. The pressure treatment step usually proceeds at room temperature although warm or hot pressing may be used. Other techniques to form the compact, as known in the art, may be substituted for the pressure treatment step. The die cavity used in this step may be a stent die cavity to allow for direct casting of the stent or alternatively, may be for some other form such as a tube or a sheet. Following the pressure treatment step, the compact has sufficient strength to allow for routine handling without breakage.
- After ejection from the die, the compact is sintered to form a coherent metal or polymer mass in the shape of the die. Alternatively, the pressure treatment step can be eliminated and the processing limited to a sintering in which the metal or polymer powder is heated in a die resulting in a low density, highly porous compound. Although the sintering step may actually partially melt the metal or polymer as in liquid-phase sintering, in the preferred embodiment, the sintering step does not melt the metal or polymer as the temperature is maintained below the melting point of elemental metal or any alloys that have formed or the polymer melting point. The sintered metal or polymer will exhibit a porosity ranging from less than 10 percent to about 80 percent of the total volume. The percentage porosity is a measure of the void space within the metal.
- Following sintering, the now porous metal or polymer may be formed into a stent, if it has not been so-formed already. Any known process in the art may be used including laser cutting and braiding of porous metal strands. FIGS. 1a and 1 b illustrate one
such stent 10, withpores 14 formed bylaser cutting apertures 18 in a sheet of porous metal. FIG. 2 illustrates astent 20 which is composed of a number ofinterconnected members 22, the members andinterconnections 24 made of a metal containing pores 26. A braided stent may be formed of a series of strands arranged in a crossing configuration which may be woven, braided or the like. The strands of porous metal or polymer can be deformed so to provide a reduced diameter of the stent which facilitates its delivery to the targeted portion of a vessel or other passageway and once disposed at the target portion the stent can then be allowed to expand to its preformed configuration and larger diameter. - The stents of the present invention may be prepared in a range of porosities allowing for the production of stents with differing drug delivery characteristics. The porosity may be between twenty and eighty percent of the total volume and more suitably between forty and sixty percent of the volume.
- The stent may be impregnated with one or more drugs by any known process in the art including high pressure loading in which the stent is placed in a bath of the desired drug or drugs and subjected to high pressure or, alternatively, subjected to a vacuum. The drug may be carried in a volatile or non-volatile solution. In the case of a volatile solution, following loading of the drug, the volatile carrier solution may be volatilized. In the case of the vacuum, the air in the pores of the metal stent is evacuated and replaced by the drug-containing solution.
- In accordance with the present invention, the stent may further be coated with one or more layers of one or more drugs to allow for longer term drug elution optionally employing a number of different drugs over time. As such, the drug in the pores would not be eluted until the coating of drug has been absorbed, thereby allowing for longer term drug treatment than would be available from the coated metal alone.
- FIG. 3 shows a
coil stent 30 in which theporous metal stent 30 further comprises such a coating 32 (the pores have been omitted for clarity). - The inventive stent may also be formed from a rolled up flat sheet comprised of a porous metal or polymer as shown in FIG. 4a. The
sheet 35 contains a plurality ofapertures 36 andpores 38 as well astabs 37. The tabs are inserted into theholes 36 a-c when the stent is rolled, as shown in FIG. 4b. The stent may be rolled tightly for delivery and implantation and be self-expandable to the extent that it tends to unroll. The stent may further be laminated with a layer of drug over the porous surface of the stent. Otherwise, it may simply be expanded by independent expansion means such as a balloon catheter positioned inside the stent as is already known in the art. - Another embodiment of the invention contemplates the fabrication of any stent design per se taken from the prior art, the stent prepared from a porous metal or polymer, the pores of the metal or polymer including one or more drugs.
- Another embodiment of the invention is an expandable intraluminal stent comprising a main body portion having a first end, a second end and a flow passage defined therethrough, the main body portion being sized for intraluminal placement within a body passage and subsequent expansion for implantation, the main body portion being further characterized in that it is formed at least in part of at least two metals, the two metals comprising a first porous metal characterized by a first porosity and mean pore size and a second porous metal characterized by a second porosity and mean pore size. FIG. 5 depicts one such stent,40, the
first metal 42 containing first pores 44 therein and thesecond metal 46 containingsecond pores 48 therein. - In the above embodiment, one drug may be loaded into the pores of the first porous metal and a second drug loaded into the pores of the second porous metal. Alternatively, the same drug can be loaded into both the first and second porous metals.
- The present invention is also directed to a method for making a porous metal, expandable intraluminal stent comprising the steps of providing a powdered metal or polymeric material, subjecting the powder to high pressure to form a compact, sintering the compact to form a final porous metal or polymer, forming a stent from the porous metal and, optionally, loading at least one drug into the pores. The drug(s) may be loaded into the pores by placing the stent in a liquid bath comprising the at least one drug at high pressure, by placing the stent in a liquid bath within a chamber, the liquid bath comprising the drug(s), and reducing the pressure within the chamber below ambient pressure or by any other method known in the art.
- In yet another embodiment, the invention is directed to a method of making an expandable intraluminal stent of varying porosity comprising the steps of providing two or more metal and/or polymeric powders in a die, subjecting the two or more powders to high pressure to form a compact, sintering the compact to form a final porous metal or polymer of varying porosity, forming a stent from the porous metal or polymer and, optionally, loading at least one drug into the pores. The two or more powdered metals and/or polymers can comprise at least two different metals and/or polymers or can comprise one metal or polymer, the one metal or polymer provided in at least two different average particle sizes or can comprise several different metals or polymers provided in several different average particle sizes. In such a way, the porosity of the stent in different regions of the stent can be tailored by forming the stent of several different powdered metals or polymers comprising a combination of different elemental metals or alloys or polymers in powdered form, or using the same elemental metal, alloy or polymer but providing it in several powders of different average particle size or by some combination of different metals and/or polymers and same metals and/or polymers of different particle size.
- While the invention has been described in connection with what is presently considered to be the most practical and preferred embodiments, it is to be understood that the invention is not to be limited to the disclosed embodiments but, on the contrary, is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the appended claims.
- The above Examples and disclosure are intended to be illustrative and not exhaustive. These examples and description will suggest many variations and alternatives to one of ordinary skill in this art. All these alternatives and variations are intended to be included within the scope of the attached claims. Those familiar with the art may recognize other equivalents to the specific embodiments described herein which equivalents are also intended to be encompassed by the claims attached hereto.
Claims (22)
1. A method of forming a stent comprising the steps of:
providing a first powdered metal;
providing a second powdered metal, the first powdered metal and second powdered metal having a different composition or different physical properties or both;
treating the first and second powdered metals to form a stent-preform;
forming a stent from the stent preform.
2. The method of wherein the stent preform is a sheet.
claim 1
3. The method of wherein the sheet is rolled into tubular form during the forming step.
claim 2
4. The method of , the sheet having opposing edges, wherein an edge is secured to an opposing edge during the forming step.
claim 3
5. The method of where the preform is laser cut during the forming step.
claim 1
6. The method of wherein the stent preform is a tube.
claim 1
7. The method of wherein the treating step includes subjecting the first and second powdered metals to high pressure to form the preform.
claim 1
8. The method of wherein the treating step includes subjecting the first and second powdered metals to high pressure to form a compact and sintering the compact to form the preform.
claim 1
9. The method of wherein the treating step includes sintering the first and second powdered metals to form the preform.
claim 1
10. The method of wherein:
claim 1
the treating step includes subjecting the first and second powdered metals to high pressure to form a compact and sintering the compact to form a preform selected from the group consisting of sheets and tubes and either
rolling the preform in the case where the preform is a sheet to form the stent or
laser cutting the preform in the case where the preform is a tube to form the stent.
11. The method of wherein the first and second metals are characterized by different average particle size.
claim 1
12. The method of wherein the first and second metals are elementally different metals.
claim 1
13. A method of forming a stent comprising the steps of:
providing a tube formed from a powdered metal;
cutting the tube to a desired shape using a laser.
14. The method of wherein the powdered metal has been sintered.
claim 13
15. The method of wherein the powdered metal has been subjected to high pressure to form a compact and the compact sintered.
claim 13
16. The method of wherein the tube is formed from at least two powdered metals, a first powdered metal and a second powdered metal, the first and second powdered metals having a different composition or different physical properties or both.
claim 15
17. The method of wherein the tube is formed from at least two powdered metals, a first powdered metal and a second powdered metal, the first and second powdered metals having a different composition or different physical properties or both.
claim 13
18. A method of forming a stent comprising the steps of:
providing a sheet formed from at least one powdered metal;
rolling the sheet to form a tubular stent.
19. The method of wherein the sheet has been sintered.
claim 18
20. The method of wherein the powdered metal has been subjected to high pressure to form a compact and the compact sintered.
claim 18
21. The method of wherein the sheet is formed from at least two powdered metals, a first powdered metal and a second powdered metal, the first and second powdered metals having a different composition or different physical properties or both. which are characterized
claim 20
22. The method of wherein the sheet is formed from at least two powdered metals, a first powdered metal and a second powdered metal, the first and second powdered metals having a different composition or different physical properties or both.
claim 18
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/880,615 US20010029660A1 (en) | 1997-09-30 | 2001-06-13 | Stent drug delivery system |
US12/171,679 US7963990B2 (en) | 1997-09-30 | 2008-07-11 | Stent drug delivery system |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/940,696 US5972027A (en) | 1997-09-30 | 1997-09-30 | Porous stent drug delivery system |
US09/420,094 US6253443B1 (en) | 1997-09-30 | 1999-10-18 | Method of forming a stent |
US09/880,615 US20010029660A1 (en) | 1997-09-30 | 2001-06-13 | Stent drug delivery system |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/420,094 Continuation US6253443B1 (en) | 1997-09-30 | 1999-10-18 | Method of forming a stent |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/171,679 Continuation US7963990B2 (en) | 1997-09-30 | 2008-07-11 | Stent drug delivery system |
Publications (1)
Publication Number | Publication Date |
---|---|
US20010029660A1 true US20010029660A1 (en) | 2001-10-18 |
Family
ID=25475270
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/940,696 Expired - Lifetime US5972027A (en) | 1997-09-30 | 1997-09-30 | Porous stent drug delivery system |
US09/420,094 Expired - Lifetime US6253443B1 (en) | 1997-09-30 | 1999-10-18 | Method of forming a stent |
US09/880,615 Abandoned US20010029660A1 (en) | 1997-09-30 | 2001-06-13 | Stent drug delivery system |
US12/171,679 Expired - Fee Related US7963990B2 (en) | 1997-09-30 | 2008-07-11 | Stent drug delivery system |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/940,696 Expired - Lifetime US5972027A (en) | 1997-09-30 | 1997-09-30 | Porous stent drug delivery system |
US09/420,094 Expired - Lifetime US6253443B1 (en) | 1997-09-30 | 1999-10-18 | Method of forming a stent |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/171,679 Expired - Fee Related US7963990B2 (en) | 1997-09-30 | 2008-07-11 | Stent drug delivery system |
Country Status (2)
Country | Link |
---|---|
US (4) | US5972027A (en) |
WO (1) | WO1999016386A1 (en) |
Cited By (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030153536A1 (en) * | 2001-10-25 | 2003-08-14 | Mitchell Glass | Compounds and methods of treating transplant rejection |
US20030181973A1 (en) * | 2002-03-20 | 2003-09-25 | Harvinder Sahota | Reduced restenosis drug containing stents |
US20030181520A1 (en) * | 2001-11-09 | 2003-09-25 | Mitchell Glass | Methods of reversing and preventing cardiovascular pathologies |
EP1348405A1 (en) * | 2002-03-29 | 2003-10-01 | Advanced Laser Applications Holding S.A. | Improved intraluminar perforated radially expandable drug delivery prosthesis |
US20040082807A1 (en) * | 2002-07-12 | 2004-04-29 | Meng Charles Q. | Novel salt forms of poorly soluble probucol esters and ethers |
US20040215169A1 (en) * | 2003-04-28 | 2004-10-28 | Scimed Life Systems, Inc. | Drug-loaded medical device |
US20040236412A1 (en) * | 2003-05-23 | 2004-11-25 | Brar Balbir S. | Treatment of stenotic regions |
US20040236414A1 (en) * | 2003-05-23 | 2004-11-25 | Brar Balbir S. | Devices and methods for treatment of stenotic regions |
US20040237282A1 (en) * | 2003-06-02 | 2004-12-02 | Hines Richard A. | Process for forming a porous drug delivery layer |
US20040260391A1 (en) * | 1999-11-17 | 2004-12-23 | Santini John T. | Stent for controlled release of drug |
US20050015142A1 (en) * | 2003-03-10 | 2005-01-20 | Michael Austin | Coated medical device and method for manufacturing the same |
US20050060021A1 (en) * | 2003-09-16 | 2005-03-17 | O'brien Barry | Medical devices |
US20050119723A1 (en) * | 2003-11-28 | 2005-06-02 | Medlogics Device Corporation | Medical device with porous surface containing bioerodable bioactive composites and related methods |
US20050186250A1 (en) * | 2001-09-19 | 2005-08-25 | Medlogics Device Corporation | Metallic structures incorporating bioactive materials and methods for creating the same |
EP1576936A1 (en) * | 2004-03-16 | 2005-09-21 | Admedes Schuessler GmbH | Stent with a strut structure |
US20050278016A1 (en) * | 2001-11-30 | 2005-12-15 | Scimed Life Systems, Inc. | Stent designed for the delivery of therapeutic substance or other agents |
US20060085062A1 (en) * | 2003-11-28 | 2006-04-20 | Medlogics Device Corporation | Implantable stent with endothelialization factor |
US20070073385A1 (en) * | 2005-09-20 | 2007-03-29 | Cook Incorporated | Eluting, implantable medical device |
US20080058919A1 (en) * | 2006-08-01 | 2008-03-06 | Kramer-Brown Pamela A | Composite polymeric and metallic stent with radiopacity |
WO2008034007A2 (en) * | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Medical devices |
US20090024199A1 (en) * | 2007-07-16 | 2009-01-22 | Medtronic Vascular, Inc. | Controlled Porosity Stent |
WO2009070447A1 (en) * | 2007-11-28 | 2009-06-04 | Boston Scientific Scimed, Inc. | Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment |
US20090240324A1 (en) * | 2008-03-19 | 2009-09-24 | Boston Scientific Scimed, Inc. | Drug Eluting Stent and Method of Making the Same |
US20100082096A1 (en) * | 2008-09-30 | 2010-04-01 | Boston Scientific Scimed, Inc. | Tailored Luminal & Abluminal Drug Elution |
US20110014264A1 (en) * | 2004-12-09 | 2011-01-20 | Boston Scientific Scimed, Inc. | Medical Devices Having Nanostructured Regions For Controlled Tissue Biocompatibility And Drug Delivery |
US7892221B2 (en) | 1996-07-02 | 2011-02-22 | Massachusetts Institute Of Technology | Method of controlled drug delivery from implant device |
US7931683B2 (en) | 2007-07-27 | 2011-04-26 | Boston Scientific Scimed, Inc. | Articles having ceramic coated surfaces |
US7938855B2 (en) | 2007-11-02 | 2011-05-10 | Boston Scientific Scimed, Inc. | Deformable underlayer for stent |
US7942926B2 (en) | 2007-07-11 | 2011-05-17 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US7955382B2 (en) | 2006-09-15 | 2011-06-07 | Boston Scientific Scimed, Inc. | Endoprosthesis with adjustable surface features |
US7976915B2 (en) | 2007-05-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Endoprosthesis with select ceramic morphology |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8002821B2 (en) | 2006-09-18 | 2011-08-23 | Boston Scientific Scimed, Inc. | Bioerodible metallic ENDOPROSTHESES |
US8002823B2 (en) | 2007-07-11 | 2011-08-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8029554B2 (en) | 2007-11-02 | 2011-10-04 | Boston Scientific Scimed, Inc. | Stent with embedded material |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US8052744B2 (en) | 2006-09-15 | 2011-11-08 | Boston Scientific Scimed, Inc. | Medical devices and methods of making the same |
US8052743B2 (en) | 2006-08-02 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US8057534B2 (en) | 2006-09-15 | 2011-11-15 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
US8066763B2 (en) | 1998-04-11 | 2011-11-29 | Boston Scientific Scimed, Inc. | Drug-releasing stent with ceramic-containing layer |
US8070797B2 (en) | 2007-03-01 | 2011-12-06 | Boston Scientific Scimed, Inc. | Medical device with a porous surface for delivery of a therapeutic agent |
US8071156B2 (en) | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8080055B2 (en) | 2006-12-28 | 2011-12-20 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US8128689B2 (en) | 2006-09-15 | 2012-03-06 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis with biostable inorganic layers |
US8137397B2 (en) * | 2004-02-26 | 2012-03-20 | Boston Scientific Scimed, Inc. | Medical devices |
US8182527B2 (en) | 2001-05-07 | 2012-05-22 | Cordis Corporation | Heparin barrier coating for controlled drug release |
US8187620B2 (en) | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8221822B2 (en) | 2007-07-31 | 2012-07-17 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
US8231980B2 (en) | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
US8236048B2 (en) | 2000-05-12 | 2012-08-07 | Cordis Corporation | Drug/drug delivery systems for the prevention and treatment of vascular disease |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8267992B2 (en) | 2009-03-02 | 2012-09-18 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US8287937B2 (en) | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
US8303643B2 (en) | 2001-06-27 | 2012-11-06 | Remon Medical Technologies Ltd. | Method and device for electrochemical formation of therapeutic species in vivo |
US8303609B2 (en) | 2000-09-29 | 2012-11-06 | Cordis Corporation | Coated medical devices |
US8353949B2 (en) | 2006-09-14 | 2013-01-15 | Boston Scientific Scimed, Inc. | Medical devices with drug-eluting coating |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
US8431149B2 (en) | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
US8449603B2 (en) | 2008-06-18 | 2013-05-28 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8574615B2 (en) | 2006-03-24 | 2013-11-05 | Boston Scientific Scimed, Inc. | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8668732B2 (en) | 2010-03-23 | 2014-03-11 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
US8771343B2 (en) | 2006-06-29 | 2014-07-08 | Boston Scientific Scimed, Inc. | Medical devices with selective titanium oxide coatings |
US8808726B2 (en) | 2006-09-15 | 2014-08-19 | Boston Scientific Scimed. Inc. | Bioerodible endoprostheses and methods of making the same |
US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
US8815273B2 (en) | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8858616B2 (en) | 2004-03-16 | 2014-10-14 | Admedes Schuessler Gmbh | Stent having a bridge structure |
US8900292B2 (en) | 2007-08-03 | 2014-12-02 | Boston Scientific Scimed, Inc. | Coating for medical device having increased surface area |
US8920491B2 (en) | 2008-04-22 | 2014-12-30 | Boston Scientific Scimed, Inc. | Medical devices having a coating of inorganic material |
US8920826B2 (en) | 2002-07-31 | 2014-12-30 | Boston Scientific Scimed, Inc. | Medical imaging reference devices |
US8932346B2 (en) | 2008-04-24 | 2015-01-13 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
US9284409B2 (en) | 2007-07-19 | 2016-03-15 | Boston Scientific Scimed, Inc. | Endoprosthesis having a non-fouling surface |
US11096774B2 (en) | 2016-12-09 | 2021-08-24 | Zenflow, Inc. | Systems, devices, and methods for the accurate deployment of an implant in the prostatic urethra |
US11890213B2 (en) | 2019-11-19 | 2024-02-06 | Zenflow, Inc. | Systems, devices, and methods for the accurate deployment and imaging of an implant in the prostatic urethra |
Families Citing this family (433)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6248129B1 (en) * | 1990-09-14 | 2001-06-19 | Quanam Medical Corporation | Expandable polymeric stent with memory and delivery apparatus and method |
US20020055710A1 (en) * | 1998-04-30 | 2002-05-09 | Ronald J. Tuch | Medical device for delivering a therapeutic agent and method of preparation |
US7963997B2 (en) * | 2002-07-19 | 2011-06-21 | Kensey Nash Corporation | Device for regeneration of articular cartilage and other tissue |
US8795242B2 (en) * | 1994-05-13 | 2014-08-05 | Kensey Nash Corporation | Resorbable polymeric device for localized drug delivery |
US6235053B1 (en) | 1998-02-02 | 2001-05-22 | G. David Jang | Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal connectors |
US6783543B2 (en) * | 2000-06-05 | 2004-08-31 | Scimed Life Systems, Inc. | Intravascular stent with increasing coating retaining capacity |
US20040106985A1 (en) | 1996-04-26 | 2004-06-03 | Jang G. David | Intravascular stent |
JP4636634B2 (en) * | 1996-04-26 | 2011-02-23 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Intravascular stent |
US7341598B2 (en) * | 1999-01-13 | 2008-03-11 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US7959664B2 (en) | 1996-12-26 | 2011-06-14 | Medinol, Ltd. | Flat process of drug coating for stents |
IT1289815B1 (en) * | 1996-12-30 | 1998-10-16 | Sorin Biomedica Cardio Spa | ANGIOPLASTIC STENT AND RELATED PRODUCTION PROCESS |
US10028851B2 (en) * | 1997-04-15 | 2018-07-24 | Advanced Cardiovascular Systems, Inc. | Coatings for controlling erosion of a substrate of an implantable medical device |
US6240616B1 (en) * | 1997-04-15 | 2001-06-05 | Advanced Cardiovascular Systems, Inc. | Method of manufacturing a medicated porous metal prosthesis |
US8172897B2 (en) | 1997-04-15 | 2012-05-08 | Advanced Cardiovascular Systems, Inc. | Polymer and metal composite implantable medical devices |
US8790391B2 (en) * | 1997-04-18 | 2014-07-29 | Cordis Corporation | Methods and devices for delivering therapeutic agents to target vessels |
US6273913B1 (en) * | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
US6203536B1 (en) | 1997-06-17 | 2001-03-20 | Medtronic, Inc. | Medical device for delivering a therapeutic substance and method therefor |
US20040130599A1 (en) * | 1997-07-15 | 2004-07-08 | Silverbrook Research Pty Ltd | Ink jet printhead with amorphous ceramic chamber |
US6890546B2 (en) | 1998-09-24 | 2005-05-10 | Abbott Laboratories | Medical devices containing rapamycin analogs |
US5972027A (en) * | 1997-09-30 | 1999-10-26 | Scimed Life Systems, Inc | Porous stent drug delivery system |
DE19746882A1 (en) * | 1997-10-23 | 1999-04-29 | Angiomed Ag | Expandable stent for tubular anatomical structures such as bile-ducts |
DK174814B1 (en) * | 1998-02-25 | 2003-12-01 | Cook William Europ | stent device |
US7208010B2 (en) | 2000-10-16 | 2007-04-24 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
US7179289B2 (en) | 1998-03-30 | 2007-02-20 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
US6241762B1 (en) | 1998-03-30 | 2001-06-05 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
US20040254635A1 (en) | 1998-03-30 | 2004-12-16 | Shanley John F. | Expandable medical device for delivery of beneficial agent |
US20070087028A1 (en) * | 1998-04-16 | 2007-04-19 | Robert Falotico | Intraluminal devices for the prevention and treatment of vascular disease |
US6013099A (en) | 1998-04-29 | 2000-01-11 | Medtronic, Inc. | Medical device for delivering a water-insoluble therapeutic salt or substance |
WO1999056663A2 (en) * | 1998-05-05 | 1999-11-11 | Scimed Life Systems, Inc. | Stent with smooth ends |
US6015433A (en) * | 1998-05-29 | 2000-01-18 | Micro Therapeutics, Inc. | Rolled stent with waveform perforation pattern |
US6652581B1 (en) * | 1998-07-07 | 2003-11-25 | Boston Scientific Scimed, Inc. | Medical device with porous surface for controlled drug release and method of making the same |
US20020038146A1 (en) * | 1998-07-29 | 2002-03-28 | Ulf Harry | Expandable stent with relief cuts for carrying medicines and other materials |
US6682554B2 (en) * | 1998-09-05 | 2004-01-27 | Jomed Gmbh | Methods and apparatus for a stent having an expandable web structure |
US6755856B2 (en) | 1998-09-05 | 2004-06-29 | Abbott Laboratories Vascular Enterprises Limited | Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation |
US7887578B2 (en) | 1998-09-05 | 2011-02-15 | Abbott Laboratories Vascular Enterprises Limited | Stent having an expandable web structure |
US7815763B2 (en) | 2001-09-28 | 2010-10-19 | Abbott Laboratories Vascular Enterprises Limited | Porous membranes for medical implants and methods of manufacture |
US20040043068A1 (en) * | 1998-09-29 | 2004-03-04 | Eugene Tedeschi | Uses for medical devices having a lubricious, nitric oxide-releasing coating |
US6168619B1 (en) * | 1998-10-16 | 2001-01-02 | Quanam Medical Corporation | Intravascular stent having a coaxial polymer member and end sleeves |
US6293967B1 (en) | 1998-10-29 | 2001-09-25 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
DE19855421C2 (en) * | 1998-11-02 | 2001-09-20 | Alcove Surfaces Gmbh | Implant |
DE19921088C2 (en) * | 1999-04-30 | 2003-08-07 | Magforce Applic Gmbh | Stent to keep aisle-like structures open |
US6258121B1 (en) * | 1999-07-02 | 2001-07-10 | Scimed Life Systems, Inc. | Stent coating |
US6379381B1 (en) | 1999-09-03 | 2002-04-30 | Advanced Cardiovascular Systems, Inc. | Porous prosthesis and a method of depositing substances into the pores |
US20070032853A1 (en) | 2002-03-27 | 2007-02-08 | Hossainy Syed F | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
DE60032912T2 (en) * | 1999-09-03 | 2007-10-25 | Advanced Cardiovascular Systems, Inc., Santa Clara | POROUS PROSTHESIS AND METHOD FOR THE DEPOSITION OF SUBSTANCES IN THE PORES |
US7807211B2 (en) * | 1999-09-03 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Thermal treatment of an implantable medical device |
US6287628B1 (en) | 1999-09-03 | 2001-09-11 | Advanced Cardiovascular Systems, Inc. | Porous prosthesis and a method of depositing substances into the pores |
US6254631B1 (en) * | 1999-09-23 | 2001-07-03 | Intratherapeutics, Inc. | Stent with enhanced friction |
US6733513B2 (en) | 1999-11-04 | 2004-05-11 | Advanced Bioprosthetic Surfaces, Ltd. | Balloon catheter having metal balloon and method of making same |
US7736687B2 (en) | 2006-01-31 | 2010-06-15 | Advance Bio Prosthetic Surfaces, Ltd. | Methods of making medical devices |
US7235092B2 (en) | 1999-11-19 | 2007-06-26 | Advanced Bio Prosthetic Surfaces, Ltd. | Guidewires and thin film catheter-sheaths and method of making same |
US10172730B2 (en) | 1999-11-19 | 2019-01-08 | Vactronix Scientific, Llc | Stents with metallic covers and methods of making same |
US7300457B2 (en) | 1999-11-19 | 2007-11-27 | Advanced Bio Prosthetic Surfaces, Ltd. | Self-supporting metallic implantable grafts, compliant implantable medical devices and methods of making same |
US8458879B2 (en) * | 2001-07-03 | 2013-06-11 | Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc. | Method of fabricating an implantable medical device |
US6537310B1 (en) | 1999-11-19 | 2003-03-25 | Advanced Bio Prosthetic Surfaces, Ltd. | Endoluminal implantable devices and method of making same |
US6936066B2 (en) | 1999-11-19 | 2005-08-30 | Advanced Bio Prosthetic Surfaces, Ltd. | Complaint implantable medical devices and methods of making same |
US6379383B1 (en) | 1999-11-19 | 2002-04-30 | Advanced Bio Prosthetic Surfaces, Ltd. | Endoluminal device exhibiting improved endothelialization and method of manufacture thereof |
US6849085B2 (en) | 1999-11-19 | 2005-02-01 | Advanced Bio Prosthetic Surfaces, Ltd. | Self-supporting laminated films, structural materials and medical devices manufactured therefrom and method of making same |
SE0000285D0 (en) * | 1999-12-07 | 2000-01-31 | Mika Lahtinen | Medical implant |
EP1235560B1 (en) * | 1999-12-10 | 2006-04-19 | Massachusetts Institute Of Technology | Microchip devices for delivery of molecules and methods of fabrication thereof |
US7278195B2 (en) * | 1999-12-16 | 2007-10-09 | Israel Aircraft Industries Ltd. | Method for producing a coated medical support device |
US6312463B1 (en) | 2000-02-01 | 2001-11-06 | Endotex Interventional Systems, Inc. | Micro-porous mesh stent with hybrid structure |
ES2420279T3 (en) | 2000-03-02 | 2013-08-23 | Microchips, Inc. | Microfabricated devices and methods for storage and selective exposure of chemicals |
EP1132058A1 (en) * | 2000-03-06 | 2001-09-12 | Advanced Laser Applications Holding S.A. | Intravascular prothesis |
US6695865B2 (en) | 2000-03-20 | 2004-02-24 | Advanced Bio Prosthetic Surfaces, Ltd. | Embolic protection device |
AU2001253479A1 (en) * | 2000-04-13 | 2001-10-30 | Sts Biopolymers, Inc. | Targeted therapeutic agent release devices and methods of making and using the same |
US6451050B1 (en) * | 2000-04-28 | 2002-09-17 | Cardiovasc, Inc. | Stent graft and method |
US6776796B2 (en) | 2000-05-12 | 2004-08-17 | Cordis Corportation | Antiinflammatory drug and delivery device |
US8845713B2 (en) | 2000-05-12 | 2014-09-30 | Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc. | Self-supporting laminated films, structural materials and medical devices manufactured therefrom and methods of making same |
US8252044B1 (en) * | 2000-11-17 | 2012-08-28 | Advanced Bio Prosthestic Surfaces, Ltd. | Device for in vivo delivery of bioactive agents and method of manufacture thereof |
AU6539101A (en) * | 2000-06-05 | 2001-12-17 | G David Jang | Intravascular stent with increasing coating retaining capacity |
US6585765B1 (en) | 2000-06-29 | 2003-07-01 | Advanced Cardiovascular Systems, Inc. | Implantable device having substances impregnated therein and a method of impregnating the same |
IL137090A (en) * | 2000-06-29 | 2010-04-15 | Pentech Medical Devices Ltd | Polymeric stent |
US6709451B1 (en) * | 2000-07-14 | 2004-03-23 | Norman Noble, Inc. | Channeled vascular stent apparatus and method |
US20040158317A1 (en) * | 2000-07-18 | 2004-08-12 | Pharmasonics, Inc. | Coated stent with ultrasound therapy |
DE10044043A1 (en) * | 2000-08-30 | 2002-03-14 | Biotronik Mess & Therapieg | Repositionable stent |
US20060177416A1 (en) | 2003-10-14 | 2006-08-10 | Medivas, Llc | Polymer particle delivery compositions and methods of use |
DE60135352D1 (en) * | 2000-08-30 | 2008-09-25 | Univ Johns Hopkins | DEVICE FOR INTRA-OCCULAR ACTIVE AGGREGATION |
US7766956B2 (en) | 2000-09-22 | 2010-08-03 | Boston Scientific Scimed, Inc. | Intravascular stent and assembly |
GB0023807D0 (en) * | 2000-09-28 | 2000-11-08 | Angiomed Ag | Prosthesis carrying releasable substance |
US6805898B1 (en) * | 2000-09-28 | 2004-10-19 | Advanced Cardiovascular Systems, Inc. | Surface features of an implantable medical device |
DE20122506U1 (en) * | 2000-10-16 | 2005-12-08 | Conor Medsystems, Inc., Menlo Park | Expandable medical device for delivering a beneficial agent |
US6764507B2 (en) | 2000-10-16 | 2004-07-20 | Conor Medsystems, Inc. | Expandable medical device with improved spatial distribution |
US7037330B1 (en) * | 2000-10-16 | 2006-05-02 | Scimed Life Systems, Inc. | Neurovascular stent and method |
US6506437B1 (en) | 2000-10-17 | 2003-01-14 | Advanced Cardiovascular Systems, Inc. | Methods of coating an implantable device having depots formed in a surface thereof |
US6979347B1 (en) | 2000-10-23 | 2005-12-27 | Advanced Cardiovascular Systems, Inc. | Implantable drug delivery prosthesis |
US6558733B1 (en) | 2000-10-26 | 2003-05-06 | Advanced Cardiovascular Systems, Inc. | Method for etching a micropatterned microdepot prosthesis |
US6783793B1 (en) * | 2000-10-26 | 2004-08-31 | Advanced Cardiovascular Systems, Inc. | Selective coating of medical devices |
US6758859B1 (en) * | 2000-10-30 | 2004-07-06 | Kenny L. Dang | Increased drug-loading and reduced stress drug delivery device |
AU2002233936A1 (en) | 2000-11-07 | 2002-05-21 | Advanced Bio Prosthetic Surfaces, Ltd. | Endoluminal stent, self-fupporting endoluminal graft and methods of making same |
US6641776B1 (en) * | 2000-11-15 | 2003-11-04 | Scimed Life Systems, Inc. | Method for preparing radiopaque surgical implement |
US10398830B2 (en) * | 2000-11-17 | 2019-09-03 | Vactronix Scientific, Llc | Device for in vivo delivery of bioactive agents and method of manufacture thereof |
US9107605B2 (en) * | 2000-11-17 | 2015-08-18 | Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc. | Device for in vivo delivery of bioactive agents and method of manufacture thereof |
US20020082678A1 (en) * | 2000-12-22 | 2002-06-27 | Motasim Sirhan | Intravascular delivery of mizoribine |
US6939375B2 (en) | 2000-12-22 | 2005-09-06 | Avantac Vascular Corporation | Apparatus and methods for controlled substance delivery from implanted prostheses |
US7077859B2 (en) * | 2000-12-22 | 2006-07-18 | Avantec Vascular Corporation | Apparatus and methods for variably controlled substance delivery from implanted prostheses |
US20050125054A1 (en) * | 2000-12-22 | 2005-06-09 | Avantec Vascular Corporation | Devices delivering therapeutic agents and methods regarding the same |
US20020082679A1 (en) * | 2000-12-22 | 2002-06-27 | Avantec Vascular Corporation | Delivery or therapeutic capable agents |
US20030033007A1 (en) * | 2000-12-22 | 2003-02-13 | Avantec Vascular Corporation | Methods and devices for delivery of therapeutic capable agents with variable release profile |
US7018405B2 (en) | 2000-12-22 | 2006-03-28 | Avantec Vascular Corporation | Intravascular delivery of methylprednisolone |
US20050203612A1 (en) * | 2000-12-22 | 2005-09-15 | Avantec Vascular Corporation | Devices delivering therapeutic agents and methods regarding the same |
US6471980B2 (en) | 2000-12-22 | 2002-10-29 | Avantec Vascular Corporation | Intravascular delivery of mycophenolic acid |
US20030050692A1 (en) * | 2000-12-22 | 2003-03-13 | Avantec Vascular Corporation | Delivery of therapeutic capable agents |
US7083642B2 (en) * | 2000-12-22 | 2006-08-01 | Avantec Vascular Corporation | Delivery of therapeutic capable agents |
US6913617B1 (en) * | 2000-12-27 | 2005-07-05 | Advanced Cardiovascular Systems, Inc. | Method for creating a textured surface on an implantable medical device |
US6547812B1 (en) | 2000-12-29 | 2003-04-15 | Advanced Cardiovascular Systems, Inc. | Radiation therapy using a radioactive implantable device and a radiosensitizer agent |
US6635082B1 (en) | 2000-12-29 | 2003-10-21 | Advanced Cardiovascular Systems Inc. | Radiopaque stent |
US6641607B1 (en) | 2000-12-29 | 2003-11-04 | Advanced Cardiovascular Systems, Inc. | Double tube stent |
US6544582B1 (en) * | 2001-01-05 | 2003-04-08 | Advanced Cardiovascular Systems, Inc. | Method and apparatus for coating an implantable device |
US6548013B2 (en) * | 2001-01-24 | 2003-04-15 | Scimed Life Systems, Inc. | Processing of particulate Ni-Ti alloy to achieve desired shape and properties |
US20040073294A1 (en) * | 2002-09-20 | 2004-04-15 | Conor Medsystems, Inc. | Method and apparatus for loading a beneficial agent into an expandable medical device |
US20040220660A1 (en) * | 2001-02-05 | 2004-11-04 | Shanley John F. | Bioresorbable stent with beneficial agent reservoirs |
KR100994543B1 (en) | 2001-02-16 | 2010-11-16 | 아스텔라스세이야쿠 가부시키가이샤 | 506 implants with fk506 |
US8123814B2 (en) | 2001-02-23 | 2012-02-28 | Biomet Manufacturing Corp. | Method and appartus for acetabular reconstruction |
US7597715B2 (en) | 2005-04-21 | 2009-10-06 | Biomet Manufacturing Corp. | Method and apparatus for use of porous implants |
US20020119178A1 (en) * | 2001-02-23 | 2002-08-29 | Luc Levesque | Drug eluting device for treating vascular diseases |
US6955686B2 (en) * | 2001-03-01 | 2005-10-18 | Cordis Corporation | Flexible stent |
US7771468B2 (en) * | 2001-03-16 | 2010-08-10 | Angiotech Biocoatings Corp. | Medicated stent having multi-layer polymer coating |
US20020138136A1 (en) * | 2001-03-23 | 2002-09-26 | Scimed Life Systems, Inc. | Medical device having radio-opacification and barrier layers |
US6764505B1 (en) | 2001-04-12 | 2004-07-20 | Advanced Cardiovascular Systems, Inc. | Variable surface area stent |
US7056339B2 (en) * | 2001-04-20 | 2006-06-06 | The Board Of Trustees Of The Leland Stanford Junior University | Drug delivery platform |
WO2002087586A1 (en) * | 2001-04-26 | 2002-11-07 | Control Delivery Systems, Inc. | Sustained release drug delivery system containing codrugs |
US20040022853A1 (en) * | 2001-04-26 | 2004-02-05 | Control Delivery Systems, Inc. | Polymer-based, sustained release drug delivery system |
EP1389975A4 (en) * | 2001-04-26 | 2009-08-26 | Vascular Innovation Inc | Endoluminal device and method for fabricating same |
US7041046B2 (en) * | 2001-05-07 | 2006-05-09 | Xoft, Inc. | Combination ionizing radiation and immunomodulator delivery devices and methods for inhibiting hyperplasia |
US6537195B2 (en) | 2001-05-07 | 2003-03-25 | Xoft, Microtube, Inc. | Combination x-ray radiation and drug delivery devices and methods for inhibiting hyperplasia |
WO2002096389A1 (en) * | 2001-05-30 | 2002-12-05 | Microchips, Inc. | Conformal coated microchip reservoir devices |
US7862495B2 (en) | 2001-05-31 | 2011-01-04 | Advanced Cardiovascular Systems, Inc. | Radiation or drug delivery source with activity gradient to minimize edge effects |
US6887215B2 (en) * | 2001-06-01 | 2005-05-03 | Boston Scientific Scimed, Inc. | Compressible ureteral stent for comfort |
US6612012B2 (en) * | 2001-06-11 | 2003-09-02 | Cordis Neurovascular, Inc. | Method of manufacturing small profile medical devices |
US6527938B2 (en) | 2001-06-21 | 2003-03-04 | Syntheon, Llc | Method for microporous surface modification of implantable metallic medical articles |
US6695920B1 (en) | 2001-06-27 | 2004-02-24 | Advanced Cardiovascular Systems, Inc. | Mandrel for supporting a stent and a method of using the mandrel to coat a stent |
JP2005505429A (en) * | 2001-06-28 | 2005-02-24 | マイクロチップス・インコーポレーテッド | Method for hermetically sealing a microchip reservoir device |
US6656216B1 (en) | 2001-06-29 | 2003-12-02 | Advanced Cardiovascular Systems, Inc. | Composite stent with regioselective material |
CA2452953A1 (en) * | 2001-07-18 | 2003-01-30 | The Research Foundation Of State University Of New York | Stent vascular intervention device and method |
ES2278952T3 (en) * | 2001-07-26 | 2007-08-16 | Avantec Vascular Corporation | DEVICES FOR MANAGING THERAPEUTIC AGENTS WITH VARIABLE LIBERATION PROFILE. |
DE10137102A1 (en) * | 2001-07-30 | 2003-02-27 | Deutsches Krebsforsch | Polyvalent vaccine against diseases caused by papillomaviruses, processes for their production and their use |
US6926733B2 (en) * | 2001-08-02 | 2005-08-09 | Boston Scientific Scimed, Inc. | Method for enhancing sheet or tubing metal stent radiopacity |
US7842083B2 (en) | 2001-08-20 | 2010-11-30 | Innovational Holdings, Llc. | Expandable medical device with improved spatial distribution |
US7056338B2 (en) * | 2003-03-28 | 2006-06-06 | Conor Medsystems, Inc. | Therapeutic agent delivery device with controlled therapeutic agent release rates |
GB0121980D0 (en) | 2001-09-11 | 2001-10-31 | Cathnet Science Holding As | Expandable stent |
IN2014DN10834A (en) * | 2001-09-17 | 2015-09-04 | Psivida Inc | |
US7776379B2 (en) * | 2001-09-19 | 2010-08-17 | Medlogics Device Corporation | Metallic structures incorporating bioactive materials and methods for creating the same |
US6863683B2 (en) | 2001-09-19 | 2005-03-08 | Abbott Laboratoris Vascular Entities Limited | Cold-molding process for loading a stent onto a stent delivery system |
WO2003028590A1 (en) * | 2001-09-24 | 2003-04-10 | Medtronic Ave Inc. | Rational drug therapy device and methods |
US6753071B1 (en) | 2001-09-27 | 2004-06-22 | Advanced Cardiovascular Systems, Inc. | Rate-reducing membrane for release of an agent |
US20030077310A1 (en) | 2001-10-22 | 2003-04-24 | Chandrashekhar Pathak | Stent coatings containing HMG-CoA reductase inhibitors |
US20030088307A1 (en) * | 2001-11-05 | 2003-05-08 | Shulze John E. | Potent coatings for stents |
US20040186551A1 (en) | 2003-01-17 | 2004-09-23 | Xtent, Inc. | Multiple independent nested stent structures and methods for their preparation and deployment |
US8080048B2 (en) * | 2001-12-03 | 2011-12-20 | Xtent, Inc. | Stent delivery for bifurcated vessels |
US7147656B2 (en) | 2001-12-03 | 2006-12-12 | Xtent, Inc. | Apparatus and methods for delivery of braided prostheses |
US7294146B2 (en) | 2001-12-03 | 2007-11-13 | Xtent, Inc. | Apparatus and methods for delivery of variable length stents |
US7137993B2 (en) | 2001-12-03 | 2006-11-21 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US7892273B2 (en) | 2001-12-03 | 2011-02-22 | Xtent, Inc. | Custom length stent apparatus |
US7351255B2 (en) | 2001-12-03 | 2008-04-01 | Xtent, Inc. | Stent delivery apparatus and method |
US7309350B2 (en) | 2001-12-03 | 2007-12-18 | Xtent, Inc. | Apparatus and methods for deployment of vascular prostheses |
US20030135266A1 (en) | 2001-12-03 | 2003-07-17 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US7182779B2 (en) | 2001-12-03 | 2007-02-27 | Xtent, Inc. | Apparatus and methods for positioning prostheses for deployment from a catheter |
US20030105512A1 (en) * | 2001-12-04 | 2003-06-05 | Nozomu Kanesaka | Stent containing medically treating material |
US6945994B2 (en) | 2001-12-05 | 2005-09-20 | Boston Scientific Scimed, Inc. | Combined balloon-expanding and self-expanding stent |
US7108771B2 (en) * | 2001-12-13 | 2006-09-19 | Advanced Technology Materials, Inc. | Method for removal of impurities in cyclic siloxanes useful as precursors for low dielectric constant thin films |
US7291165B2 (en) * | 2002-01-31 | 2007-11-06 | Boston Scientific Scimed, Inc. | Medical device for delivering biologically active material |
CN101717410B (en) | 2002-02-01 | 2015-04-29 | 阿里亚德医药股份有限公司 | Phosphorus-containing compounds & uses thereof |
US20030220249A1 (en) * | 2002-02-07 | 2003-11-27 | Hackett Perry B. | Factors for angiogenesis, vasculogenesis, cartilage formation, bone formation, and methods of use thereof |
US7008397B2 (en) | 2002-02-13 | 2006-03-07 | Percardia, Inc. | Cardiac implant and methods |
US7918883B2 (en) * | 2002-02-25 | 2011-04-05 | Boston Scientific Scimed, Inc. | Non-invasive heating of implanted vascular treatment device |
US20040038303A1 (en) * | 2002-04-08 | 2004-02-26 | Unger Gretchen M. | Biologic modulations with nanoparticles |
US7709048B2 (en) * | 2002-05-02 | 2010-05-04 | Labcoat, Ltd. | Method and apparatus for coating a medical device |
US6645547B1 (en) | 2002-05-02 | 2003-11-11 | Labcoat Ltd. | Stent coating device |
US7048962B2 (en) * | 2002-05-02 | 2006-05-23 | Labcoat, Ltd. | Stent coating device |
EP1507494A2 (en) * | 2002-05-06 | 2005-02-23 | Abbott Laboratories | Endoprosthesis for controlled contraction and expansion |
EP2529707B1 (en) * | 2002-05-08 | 2015-04-15 | Abbott Laboratories | Endoprosthesis having foot extensions |
WO2004004602A1 (en) * | 2002-07-08 | 2004-01-15 | Abbott Laboratories Vascular Enterprises Limited | Drug eluting stent and methods of manufacture |
US7343659B2 (en) * | 2002-07-10 | 2008-03-18 | Boston Scientific Scimed, Inc. | Method of making a medical device |
EP1521603B1 (en) | 2002-07-12 | 2011-01-19 | Cook Incorporated | Coated medical device |
US7951392B2 (en) * | 2002-08-16 | 2011-05-31 | Boston Scientific Scimed, Inc. | Microarray drug delivery coatings |
US20040044404A1 (en) * | 2002-08-30 | 2004-03-04 | Stucke Sean M. | Retention coatings for delivery systems |
DE60226236T3 (en) † | 2002-09-20 | 2011-12-15 | Abbott Laboratories Vascular Enterprises Ltd. | A rough-surfaced stent and its manufacturing process |
CA2499594A1 (en) * | 2002-09-20 | 2004-04-01 | Conor Medsystems, Inc. | Expandable medical device with openings for delivery of multiple beneficial agents |
US7758636B2 (en) | 2002-09-20 | 2010-07-20 | Innovational Holdings Llc | Expandable medical device with openings for delivery of multiple beneficial agents |
AU2003270817B2 (en) | 2002-09-26 | 2009-09-17 | Vactronix Scientific, Llc | High strength vacuum deposited nitionol alloy films, medical thin film graft materials and method of making same |
US20060100695A1 (en) * | 2002-09-27 | 2006-05-11 | Peacock James C Iii | Implantable stent with modified ends |
US7326238B1 (en) * | 2002-09-30 | 2008-02-05 | Abbott Cardiovascular Systems Inc. | Method and apparatus for treating vulnerable plaque |
US20060265043A1 (en) * | 2002-09-30 | 2006-11-23 | Evgenia Mandrusov | Method and apparatus for treating vulnerable plaque |
US7135038B1 (en) | 2002-09-30 | 2006-11-14 | Advanced Cardiovascular Systems, Inc. | Drug eluting stent |
US6699275B1 (en) * | 2002-10-11 | 2004-03-02 | Enteromedics Inc. | Stent and delivery system |
EP1410812A1 (en) * | 2002-10-14 | 2004-04-21 | EC (European Community) | Functionalisation of stents with lipase |
US20040088038A1 (en) * | 2002-10-30 | 2004-05-06 | Houdin Dehnad | Porous metal for drug-loaded stents |
US8524148B2 (en) * | 2002-11-07 | 2013-09-03 | Abbott Laboratories | Method of integrating therapeutic agent into a bioerodible medical device |
US8221495B2 (en) * | 2002-11-07 | 2012-07-17 | Abbott Laboratories | Integration of therapeutic agent into a bioerodible medical device |
US20040143321A1 (en) * | 2002-11-08 | 2004-07-22 | Conor Medsystems, Inc. | Expandable medical device and method for treating chronic total occlusions with local delivery of an angiogenic factor |
US20040142014A1 (en) * | 2002-11-08 | 2004-07-22 | Conor Medsystems, Inc. | Method and apparatus for reducing tissue damage after ischemic injury |
US7169178B1 (en) * | 2002-11-12 | 2007-01-30 | Advanced Cardiovascular Systems, Inc. | Stent with drug coating |
DE60322581D1 (en) * | 2002-11-13 | 2008-09-11 | Setagon Inc | MEDICAL DEVICES WITH POROUS LAYERS AND MANUFACTURING METHOD THEREFOR |
US20050070989A1 (en) * | 2002-11-13 | 2005-03-31 | Whye-Kei Lye | Medical devices having porous layers and methods for making the same |
US9770349B2 (en) * | 2002-11-13 | 2017-09-26 | University Of Virginia Patent Foundation | Nanoporous stents with enhanced cellular adhesion and reduced neointimal formation |
US20060121080A1 (en) | 2002-11-13 | 2006-06-08 | Lye Whye K | Medical devices having nanoporous layers and methods for making the same |
US7074276B1 (en) | 2002-12-12 | 2006-07-11 | Advanced Cardiovascular Systems, Inc. | Clamp mandrel fixture and a method of using the same to minimize coating defects |
US8435550B2 (en) | 2002-12-16 | 2013-05-07 | Abbot Cardiovascular Systems Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US6725901B1 (en) * | 2002-12-27 | 2004-04-27 | Advanced Cardiovascular Systems, Inc. | Methods of manufacture of fully consolidated or porous medical devices |
US20070239251A1 (en) * | 2002-12-31 | 2007-10-11 | Abbott Cardiovascular Systems Inc. | Flexible stent |
US20040236415A1 (en) * | 2003-01-02 | 2004-11-25 | Richard Thomas | Medical devices having drug releasing polymer reservoirs |
EP1610823B1 (en) | 2003-03-28 | 2011-09-28 | Innovational Holdings, LLC | Implantable medical device with continuous agent concentration gradient |
US20040243224A1 (en) * | 2003-04-03 | 2004-12-02 | Medtronic Vascular, Inc. | Methods and compositions for inhibiting narrowing in mammalian vascular pathways |
US8246974B2 (en) | 2003-05-02 | 2012-08-21 | Surmodics, Inc. | Medical devices and methods for producing the same |
EP1633320A2 (en) | 2003-05-02 | 2006-03-15 | SurModics, Inc. | Implantable controlled release bioactive agent delivery device |
US7625401B2 (en) * | 2003-05-06 | 2009-12-01 | Abbott Laboratories | Endoprosthesis having foot extensions |
US7625398B2 (en) * | 2003-05-06 | 2009-12-01 | Abbott Laboratories | Endoprosthesis having foot extensions |
US7323209B1 (en) | 2003-05-15 | 2008-01-29 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for coating stents |
US20040236278A1 (en) * | 2003-05-22 | 2004-11-25 | Atrium Medical Corp. | Therapeutic agent delivery |
US7241308B2 (en) | 2003-06-09 | 2007-07-10 | Xtent, Inc. | Stent deployment systems and methods |
US20040260315A1 (en) * | 2003-06-17 | 2004-12-23 | Dell Jeffrey R. | Expandable tissue support member and method of forming the support member |
DE10329260A1 (en) * | 2003-06-23 | 2005-01-13 | Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin | Stent with a coating system |
US20050118344A1 (en) | 2003-12-01 | 2005-06-02 | Pacetti Stephen D. | Temperature controlled crimping |
US20050043786A1 (en) * | 2003-08-18 | 2005-02-24 | Medtronic Ave, Inc. | Methods and apparatus for treatment of aneurysmal tissue |
US20050058768A1 (en) * | 2003-09-16 | 2005-03-17 | Eyal Teichman | Method for coating prosthetic stents |
US7785653B2 (en) * | 2003-09-22 | 2010-08-31 | Innovational Holdings Llc | Method and apparatus for loading a beneficial agent into an expandable medical device |
US20050070990A1 (en) * | 2003-09-26 | 2005-03-31 | Stinson Jonathan S. | Medical devices and methods of making same |
US7055237B2 (en) * | 2003-09-29 | 2006-06-06 | Medtronic Vascular, Inc. | Method of forming a drug eluting stent |
US7198675B2 (en) | 2003-09-30 | 2007-04-03 | Advanced Cardiovascular Systems | Stent mandrel fixture and method for selectively coating surfaces of a stent |
US7208172B2 (en) * | 2003-11-03 | 2007-04-24 | Medlogics Device Corporation | Metallic composite coating for delivery of therapeutic agents from the surface of implantable devices |
US7435256B2 (en) * | 2003-11-06 | 2008-10-14 | Boston Scientific Scimed, Inc. | Method and apparatus for controlled delivery of active substance |
US20050154451A1 (en) * | 2003-12-18 | 2005-07-14 | Medtronic Vascular, Inc. | Medical devices to treat or inhibit restenosis |
US20050154455A1 (en) * | 2003-12-18 | 2005-07-14 | Medtronic Vascular, Inc. | Medical devices to treat or inhibit restenosis |
US20050149174A1 (en) * | 2003-12-18 | 2005-07-07 | Medtronic Vascular, Inc. | Medical devices to treat or inhibit restenosis |
US20050137683A1 (en) * | 2003-12-19 | 2005-06-23 | Medtronic Vascular, Inc. | Medical devices to treat or inhibit restenosis |
US20050152942A1 (en) * | 2003-12-23 | 2005-07-14 | Medtronic Vascular, Inc. | Medical devices to treat or inhibit restenosis |
US20050152940A1 (en) * | 2003-12-23 | 2005-07-14 | Medtronic Vascular, Inc. | Medical devices to treat or inhibit restenosis |
US20050152943A1 (en) * | 2003-12-23 | 2005-07-14 | Medtronic Vascular, Inc. | Medical devices to treat or inhibit restenosis |
US7326236B2 (en) | 2003-12-23 | 2008-02-05 | Xtent, Inc. | Devices and methods for controlling and indicating the length of an interventional element |
US20050154452A1 (en) * | 2003-12-23 | 2005-07-14 | Medtronic Vascular, Inc. | Medical devices to treat or inhibit restenosis |
US20050143803A1 (en) * | 2003-12-24 | 2005-06-30 | Medtronic Vascular, Inc. | Protective sheath for drug coated stent |
US20050159809A1 (en) * | 2004-01-21 | 2005-07-21 | Medtronic Vascular, Inc. | Implantable medical devices for treating or preventing restenosis |
US8002822B2 (en) * | 2004-01-22 | 2011-08-23 | Isoflux, Inc. | Radiopaque coating for biomedical devices |
US7407684B2 (en) * | 2004-01-28 | 2008-08-05 | Boston Scientific Scimed, Inc. | Multi-step method of manufacturing a medical device |
US7265317B2 (en) * | 2004-01-28 | 2007-09-04 | Boston Scientific Scimed, Inc. | Method of cutting material with hybrid liquid-jet/laser system |
US7803178B2 (en) | 2004-01-30 | 2010-09-28 | Trivascular, Inc. | Inflatable porous implants and methods for drug delivery |
US20050175667A1 (en) * | 2004-02-10 | 2005-08-11 | Wenda Carlyle | Use of endothelin antagonists to prevent restenosis |
JP2007521928A (en) * | 2004-02-13 | 2007-08-09 | コナー メドシステムズ, インコーポレイテッド | Implantable drug delivery device comprising a wire filament |
US7323006B2 (en) | 2004-03-30 | 2008-01-29 | Xtent, Inc. | Rapid exchange interventional devices and methods |
US20050261762A1 (en) * | 2004-05-21 | 2005-11-24 | Medtronic Vascular, Inc. | Medical devices to prevent or inhibit restenosis |
US20050266040A1 (en) * | 2004-05-28 | 2005-12-01 | Brent Gerberding | Medical devices composed of porous metallic materials for delivering biologically active materials |
EP1753369B1 (en) | 2004-06-08 | 2013-05-29 | Advanced Stent Technologies, Inc. | Stent with protruding branch portion for bifurcated vessels |
EP1604697A1 (en) * | 2004-06-09 | 2005-12-14 | J.A.C.C. GmbH | Implantable device |
US20050278929A1 (en) * | 2004-06-16 | 2005-12-22 | National Taipei University Technology | Process of manufacturing stent with therapeutic function in the human body |
US20050288766A1 (en) | 2004-06-28 | 2005-12-29 | Xtent, Inc. | Devices and methods for controlling expandable prostheses during deployment |
US8317859B2 (en) | 2004-06-28 | 2012-11-27 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US8709469B2 (en) | 2004-06-30 | 2014-04-29 | Abbott Cardiovascular Systems Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
WO2006014484A2 (en) * | 2004-07-02 | 2006-02-09 | Surmodics, Inc. | Methods and devices for the treatment of ocular conditions |
US20060009839A1 (en) * | 2004-07-12 | 2006-01-12 | Scimed Life Systems, Inc. | Composite vascular graft including bioactive agent coating and biodegradable sheath |
US7537590B2 (en) * | 2004-07-30 | 2009-05-26 | Microchips, Inc. | Multi-reservoir device for transdermal drug delivery and sensing |
US20060034891A1 (en) * | 2004-08-12 | 2006-02-16 | Laurie Lawin | Biodegradable controlled release bioactive agent delivery device |
US9283099B2 (en) | 2004-08-25 | 2016-03-15 | Advanced Cardiovascular Systems, Inc. | Stent-catheter assembly with a releasable connection for stent retention |
EP1791496B1 (en) | 2004-08-31 | 2019-07-31 | C.R. Bard, Inc. | Self-sealing ptfe graft with kink resistance |
WO2006026768A1 (en) | 2004-09-01 | 2006-03-09 | Microchips, Inc. | Multi-cap reservoir devices for controlled release or exposure of reservoir contents |
US20060062822A1 (en) * | 2004-09-21 | 2006-03-23 | Medtronic Vascular, Inc. | Medical devices to treat or inhibit restenosis |
US7901451B2 (en) | 2004-09-24 | 2011-03-08 | Biosensors International Group, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US20060088571A1 (en) * | 2004-10-21 | 2006-04-27 | Medtronic Vascular, Inc. | Biocompatible and hemocompatible polymer compositions |
US7632307B2 (en) * | 2004-12-16 | 2009-12-15 | Advanced Cardiovascular Systems, Inc. | Abluminal, multilayer coating constructs for drug-delivery stents |
US8287583B2 (en) | 2005-01-10 | 2012-10-16 | Taheri Laduca Llc | Apparatus and method for deploying an implantable device within the body |
DE102005003188A1 (en) * | 2005-01-20 | 2006-07-27 | Restate Patent Ag | Medical implant made of an amorphous or nanocrystalline alloy |
AU2006221046B2 (en) * | 2005-03-03 | 2012-02-02 | Icon Medical Corp. | Improved metal alloys for medical device |
US9107899B2 (en) | 2005-03-03 | 2015-08-18 | Icon Medical Corporation | Metal alloys for medical devices |
US7452502B2 (en) * | 2005-03-03 | 2008-11-18 | Icon Medical Corp. | Metal alloy for a stent |
US7540995B2 (en) * | 2005-03-03 | 2009-06-02 | Icon Medical Corp. | Process for forming an improved metal alloy stent |
US8292967B2 (en) | 2005-04-21 | 2012-10-23 | Biomet Manufacturing Corp. | Method and apparatus for use of porous implants |
US8266780B2 (en) | 2005-04-21 | 2012-09-18 | Biomet Manufacturing Corp. | Method and apparatus for use of porous implants |
US8066778B2 (en) | 2005-04-21 | 2011-11-29 | Biomet Manufacturing Corp. | Porous metal cup with cobalt bearing surface |
US8021432B2 (en) | 2005-12-05 | 2011-09-20 | Biomet Manufacturing Corp. | Apparatus for use of porous implants |
US20060248698A1 (en) * | 2005-05-05 | 2006-11-09 | Hanson Brian J | Tubular stent and methods of making the same |
JP2008543376A (en) * | 2005-06-08 | 2008-12-04 | シー・アール・バード・インコーポレーテッド | Grafts and stents with inorganic biocompatible calcium salts |
PT1890641T (en) | 2005-06-17 | 2017-05-30 | Bard Inc C R | Vascular graft with kink resistance after clamping |
US7622070B2 (en) * | 2005-06-20 | 2009-11-24 | Advanced Cardiovascular Systems, Inc. | Method of manufacturing an implantable polymeric medical device |
US7823533B2 (en) | 2005-06-30 | 2010-11-02 | Advanced Cardiovascular Systems, Inc. | Stent fixture and method for reducing coating defects |
EP2364676B1 (en) | 2005-06-30 | 2018-12-19 | Abbott Laboratories | Endoprosthesis having foot extensions |
US20070027530A1 (en) * | 2005-07-26 | 2007-02-01 | Medtronic Vascular, Inc. | Intraluminal device, catheter assembly, and method of use thereof |
US7735449B1 (en) | 2005-07-28 | 2010-06-15 | Advanced Cardiovascular Systems, Inc. | Stent fixture having rounded support structures and method for use thereof |
US9101949B2 (en) | 2005-08-04 | 2015-08-11 | Eilaz Babaev | Ultrasonic atomization and/or seperation system |
US7919583B2 (en) * | 2005-08-08 | 2011-04-05 | Discovery Genomics, Inc. | Integration-site directed vector systems |
US7896539B2 (en) | 2005-08-16 | 2011-03-01 | Bacoustics, Llc | Ultrasound apparatus and methods for mixing liquids and coating stents |
WO2007022496A2 (en) * | 2005-08-19 | 2007-02-22 | Icon Medical Corp. | Medical device deployment instrument |
US9248034B2 (en) | 2005-08-23 | 2016-02-02 | Advanced Cardiovascular Systems, Inc. | Controlled disintegrating implantable medical devices |
ES2574780T3 (en) * | 2005-09-06 | 2016-06-22 | C.R. Bard, Inc. | Drug Release Graft |
JP5192384B2 (en) | 2005-09-22 | 2013-05-08 | メディバス エルエルシー | Bis- (α-amino) -diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use |
WO2007038246A2 (en) | 2005-09-22 | 2007-04-05 | Medivas, Llc | Solid polymer delivery compositions and methods for use thereof |
US20070067020A1 (en) * | 2005-09-22 | 2007-03-22 | Medtronic Vasular, Inc. | Intraluminal stent, delivery system, and a method of treating a vascular condition |
US20070100431A1 (en) * | 2005-11-03 | 2007-05-03 | Craig Bonsignore | Intraluminal medical device with strain concentrating bridge |
CA2626598A1 (en) | 2005-11-09 | 2007-05-18 | C.R. Bard Inc. | Grafts and stent grafts having a radiopaque marker |
US20070112421A1 (en) * | 2005-11-14 | 2007-05-17 | O'brien Barry | Medical device with a grooved surface |
US7867547B2 (en) | 2005-12-19 | 2011-01-11 | Advanced Cardiovascular Systems, Inc. | Selectively coating luminal surfaces of stents |
US7540881B2 (en) * | 2005-12-22 | 2009-06-02 | Boston Scientific Scimed, Inc. | Bifurcation stent pattern |
US20070156230A1 (en) | 2006-01-04 | 2007-07-05 | Dugan Stephen R | Stents with radiopaque markers |
US8828077B2 (en) * | 2006-03-15 | 2014-09-09 | Medinol Ltd. | Flat process of preparing drug eluting stents |
CA2646885A1 (en) | 2006-03-20 | 2007-09-27 | Xtent, Inc. | Apparatus and methods for deployment of linked prosthetic segments |
US20070231361A1 (en) * | 2006-03-28 | 2007-10-04 | Medtronic Vascular, Inc. | Use of Fatty Acids to Inhibit the Growth of Aneurysms |
US7722735B2 (en) * | 2006-04-06 | 2010-05-25 | C3 Materials Corp. | Microstructure applique and method for making same |
US8003156B2 (en) | 2006-05-04 | 2011-08-23 | Advanced Cardiovascular Systems, Inc. | Rotatable support elements for stents |
US7985441B1 (en) | 2006-05-04 | 2011-07-26 | Yiwen Tang | Purification of polymers for coating applications |
US20070275035A1 (en) * | 2006-05-24 | 2007-11-29 | Microchips, Inc. | Minimally Invasive Medical Implant Devices for Controlled Drug Delivery |
US20130325104A1 (en) | 2006-05-26 | 2013-12-05 | Abbott Cardiovascular Systems Inc. | Stents With Radiopaque Markers |
US7872068B2 (en) | 2006-05-30 | 2011-01-18 | Incept Llc | Materials formable in situ within a medical device |
EP2023874A4 (en) * | 2006-06-02 | 2009-07-08 | Bioseek Inc | Methods for identifying agents and their use for the prevention of restenosis |
US8603530B2 (en) | 2006-06-14 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | Nanoshell therapy |
US8048448B2 (en) | 2006-06-15 | 2011-11-01 | Abbott Cardiovascular Systems Inc. | Nanoshells for drug delivery |
US8333000B2 (en) | 2006-06-19 | 2012-12-18 | Advanced Cardiovascular Systems, Inc. | Methods for improving stent retention on a balloon catheter |
US8017237B2 (en) | 2006-06-23 | 2011-09-13 | Abbott Cardiovascular Systems, Inc. | Nanoshells on polymers |
US9072820B2 (en) | 2006-06-26 | 2015-07-07 | Advanced Cardiovascular Systems, Inc. | Polymer composite stent with polymer particles |
US7757543B2 (en) | 2006-07-13 | 2010-07-20 | Advanced Cardiovascular Systems, Inc. | Radio frequency identification monitoring of stents |
US9173733B1 (en) | 2006-08-21 | 2015-11-03 | Abbott Cardiovascular Systems Inc. | Tracheobronchial implantable medical device and methods of use |
EP2066271A1 (en) * | 2006-09-18 | 2009-06-10 | Boston Scientific Limited | Medical device with porous surface |
CA2663573C (en) * | 2006-09-21 | 2015-04-07 | Cleveny Technologies | A specially configured and surface modified medical device with certain design features that utilize the intrinsic properties of tungsten, zirconium, tantalum and/or niobium |
EP2073765A2 (en) * | 2006-09-25 | 2009-07-01 | Boston Scientific Limited | Injection of therapeutic into porous regions of a medical device |
US7780730B2 (en) | 2006-09-25 | 2010-08-24 | Iyad Saidi | Nasal implant introduced through a non-surgical injection technique |
US7951191B2 (en) * | 2006-10-10 | 2011-05-31 | Boston Scientific Scimed, Inc. | Bifurcated stent with entire circumferential petal |
US9198749B2 (en) * | 2006-10-12 | 2015-12-01 | C. R. Bard, Inc. | Vascular grafts with multiple channels and methods for making |
US20080097591A1 (en) | 2006-10-20 | 2008-04-24 | Biosensors International Group | Drug-delivery endovascular stent and method of use |
US8067055B2 (en) * | 2006-10-20 | 2011-11-29 | Biosensors International Group, Ltd. | Drug-delivery endovascular stent and method of use |
DE602007011822D1 (en) * | 2006-11-16 | 2011-02-17 | Boston Scient Ltd | STENT WITH FUNCTION FOR DIFFERENT TIMES OF ABLUMINAL AND LUMINOUS RELEASE OF A TREATMENT |
US7842082B2 (en) | 2006-11-16 | 2010-11-30 | Boston Scientific Scimed, Inc. | Bifurcated stent |
ES2376405T3 (en) * | 2006-12-07 | 2012-03-13 | Mallinckrodt Llc | MEDICAL DEVICES FOR LOCALIZED MEDICINAL ADMINISTRATION. |
CA2678611A1 (en) * | 2006-12-26 | 2008-07-24 | Boston Scientific Limited | Differential drug release from a medical device |
CN101610797A (en) * | 2007-01-19 | 2009-12-23 | 金文申有限公司 | But the implant of part bio-absorbable |
EP2118079A1 (en) | 2007-02-07 | 2009-11-18 | The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services | Synthetic macrocyclic compounds for treating cancer |
US9526642B2 (en) | 2007-02-09 | 2016-12-27 | Taheri Laduca Llc | Vascular implants and methods of fabricating the same |
US20080189928A1 (en) * | 2007-02-12 | 2008-08-14 | Medtronic Vascular, Inc. | Stent Ring Surface Formation |
WO2008098922A2 (en) * | 2007-02-13 | 2008-08-21 | Cinvention Ag | Biodegradable porous stent |
AT504975B1 (en) * | 2007-02-19 | 2013-12-15 | Arc Austrian Res Centers Gmbh | GRID PART OF METAL AND METHOD FOR PRODUCING A GRID PART |
US20080199510A1 (en) | 2007-02-20 | 2008-08-21 | Xtent, Inc. | Thermo-mechanically controlled implants and methods of use |
US20080208352A1 (en) * | 2007-02-27 | 2008-08-28 | Medtronic Vascular, Inc. | Stent Having Controlled Porosity for Improved Ductility |
US8486132B2 (en) | 2007-03-22 | 2013-07-16 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US20080243234A1 (en) * | 2007-03-27 | 2008-10-02 | Medtronic Vascular, Inc. | Magnesium Alloy Stent |
US8646444B2 (en) * | 2007-03-27 | 2014-02-11 | Electrolux Home Products, Inc. | Glide rack |
CA2685965A1 (en) | 2007-03-30 | 2008-10-09 | Medivas, Llc | Bioabsorbable elastomeric polymer networks, cross-linkers and methods of use |
US20080249599A1 (en) * | 2007-04-05 | 2008-10-09 | Medtronic Vascular, Inc. | Stent With Therapeutic Agent Delivery Structures in Low Strain Regions |
WO2008124114A2 (en) * | 2007-04-09 | 2008-10-16 | Boston Scientific Limited | Stent with unconnected stent segments |
US8128679B2 (en) | 2007-05-23 | 2012-03-06 | Abbott Laboratories Vascular Enterprises Limited | Flexible stent with torque-absorbing connectors |
US8016874B2 (en) | 2007-05-23 | 2011-09-13 | Abbott Laboratories Vascular Enterprises Limited | Flexible stent with elevated scaffolding properties |
US8048441B2 (en) | 2007-06-25 | 2011-11-01 | Abbott Cardiovascular Systems, Inc. | Nanobead releasing medical devices |
US7780095B2 (en) | 2007-07-13 | 2010-08-24 | Bacoustics, Llc | Ultrasound pumping apparatus |
US7753285B2 (en) | 2007-07-13 | 2010-07-13 | Bacoustics, Llc | Echoing ultrasound atomization and/or mixing system |
US20090022772A1 (en) * | 2007-07-17 | 2009-01-22 | Medivas, Llc | Bioabsorbable elastomeric arterial support device and methods of use |
US20090157172A1 (en) * | 2007-07-24 | 2009-06-18 | Boston Scientific Scrimed, Inc. | Stents with polymer-free coatings for delivering a therapeutic agent |
US7959669B2 (en) * | 2007-09-12 | 2011-06-14 | Boston Scientific Scimed, Inc. | Bifurcated stent with open ended side branch support |
US20090076591A1 (en) * | 2007-09-19 | 2009-03-19 | Boston Scientific Scimed, Inc. | Stent Design Allowing Extended Release of Drug and/or Enhanced Adhesion of Polymer to OD Surface |
US8663309B2 (en) | 2007-09-26 | 2014-03-04 | Trivascular, Inc. | Asymmetric stent apparatus and method |
EP2052700A1 (en) * | 2007-09-26 | 2009-04-29 | Microchips, Inc. | Drug delivery device and method for use with prosthetic device implantation |
US8066755B2 (en) | 2007-09-26 | 2011-11-29 | Trivascular, Inc. | System and method of pivoted stent deployment |
US8226701B2 (en) | 2007-09-26 | 2012-07-24 | Trivascular, Inc. | Stent and delivery system for deployment thereof |
US8709071B1 (en) * | 2007-09-28 | 2014-04-29 | Abbott Cardiovascular Systems Inc. | Stent with preferential coating |
AU2008308474B2 (en) | 2007-10-04 | 2014-07-24 | Trivascular, Inc. | Modular vascular graft for low profile percutaneous delivery |
US20090105811A1 (en) * | 2007-10-18 | 2009-04-23 | Medtronic, Inc. | Intravascular Devices for Cell-Based Therapies |
US8328861B2 (en) | 2007-11-16 | 2012-12-11 | Trivascular, Inc. | Delivery system and method for bifurcated graft |
US8083789B2 (en) | 2007-11-16 | 2011-12-27 | Trivascular, Inc. | Securement assembly and method for expandable endovascular device |
US20110027379A1 (en) * | 2007-12-06 | 2011-02-03 | Cornell University | Oligo-Ethylene Glycol-Based Polymer Compositions and Methods of Use |
WO2009079282A1 (en) * | 2007-12-19 | 2009-06-25 | Icon Medical Corp. | A method for forming a tubular medical device |
US7722661B2 (en) * | 2007-12-19 | 2010-05-25 | Boston Scientific Scimed, Inc. | Stent |
US8337544B2 (en) | 2007-12-20 | 2012-12-25 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having flexible connectors |
US8920488B2 (en) | 2007-12-20 | 2014-12-30 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having a stable architecture |
US7850726B2 (en) | 2007-12-20 | 2010-12-14 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having struts linked by foot extensions |
US8277501B2 (en) * | 2007-12-21 | 2012-10-02 | Boston Scientific Scimed, Inc. | Bi-stable bifurcated stent petal geometry |
US20090196899A1 (en) * | 2008-01-31 | 2009-08-06 | Medtronic Vascular, Inc. | Controlled Alloy Stent |
US20090198321A1 (en) * | 2008-02-01 | 2009-08-06 | Boston Scientific Scimed, Inc. | Drug-Coated Medical Devices for Differential Drug Release |
US9101503B2 (en) | 2008-03-06 | 2015-08-11 | J.W. Medical Systems Ltd. | Apparatus having variable strut length and methods of use |
US20090240318A1 (en) * | 2008-03-19 | 2009-09-24 | Boston Scientific Scimed, Inc. | Stent expansion column, strut and connector slit design |
EP2110148A1 (en) * | 2008-04-18 | 2009-10-21 | von Korn, Hubertus | Polymer-free stents comprising an endothelin receptor antagonist |
US8932340B2 (en) * | 2008-05-29 | 2015-01-13 | Boston Scientific Scimed, Inc. | Bifurcated stent and delivery system |
US20090319026A1 (en) * | 2008-06-20 | 2009-12-24 | Boston Scientific Scimed, Inc. | Composite Stent with Reservoirs for Drug Delivery and Methods of Manufacturing |
CA2765670C (en) * | 2008-06-24 | 2018-05-15 | Bioactive Surgical, Inc. | Surgical sutures incorporated with stem cells or other bioactive materials |
US20100010618A1 (en) * | 2008-07-08 | 2010-01-14 | Boston Scientific Scimed, Inc. | Overlapping Stent |
US20100105140A1 (en) * | 2008-07-16 | 2010-04-29 | Fahrenkrug Scott C | Plaice dna transposon system |
US7951193B2 (en) | 2008-07-23 | 2011-05-31 | Boston Scientific Scimed, Inc. | Drug-eluting stent |
US8147898B2 (en) * | 2008-07-25 | 2012-04-03 | Medtronic Vascular, Inc. | Low temperature drug deposition |
US20100057188A1 (en) * | 2008-08-28 | 2010-03-04 | Boston Scientific Scimed, Inc. | Endoprostheses with porous regions and non-polymeric coating |
US8821562B2 (en) | 2008-09-25 | 2014-09-02 | Advanced Bifurcation Systems, Inc. | Partially crimped stent |
US8828071B2 (en) | 2008-09-25 | 2014-09-09 | Advanced Bifurcation Systems, Inc. | Methods and systems for ostial stenting of a bifurcation |
US11298252B2 (en) | 2008-09-25 | 2022-04-12 | Advanced Bifurcation Systems Inc. | Stent alignment during treatment of a bifurcation |
EP2344068B1 (en) | 2008-09-25 | 2022-10-19 | Advanced Bifurcation Systems Inc. | Partially crimped stent |
US20100114292A1 (en) * | 2008-10-31 | 2010-05-06 | Vioptix, Inc. | Vessel Extender |
US9597220B2 (en) | 2008-11-19 | 2017-03-21 | Spirox, Inc. | Apparatus and methods for correcting nasal valve collapse |
JP5400897B2 (en) * | 2008-12-30 | 2014-01-29 | クック メディカル テクノロジーズ エルエルシー | Endoscopic device with a balloon at the tip |
US20100274276A1 (en) * | 2009-04-22 | 2010-10-28 | Ricky Chow | Aneurysm treatment system, device and method |
US20100303882A1 (en) * | 2009-05-26 | 2010-12-02 | Mallinckrodt Inc. | Medical Devices for Localized Drug Delivery |
US20110066223A1 (en) * | 2009-09-14 | 2011-03-17 | Hossainy Syed F A | Bioabsorbable Stent With Time Dependent Structure And Properties |
US8425587B2 (en) * | 2009-09-17 | 2013-04-23 | Abbott Cardiovascular Systems Inc. | Method of treatment with a bioabsorbable stent with time dependent structure and properties and regio-selective degradation |
US20110070358A1 (en) * | 2009-09-20 | 2011-03-24 | Medtronic Vascular, Inc. | Method of forming hollow tubular drug eluting medical devices |
US8381774B2 (en) * | 2009-09-20 | 2013-02-26 | Medtronic Vascular, Inc. | Methods for loading a drug eluting medical device |
EP2338534A2 (en) * | 2009-12-21 | 2011-06-29 | Biotronik VI Patent AG | Medical implant, coating method and implantation method |
US8361140B2 (en) * | 2009-12-29 | 2013-01-29 | Boston Scientific Scimed, Inc. | High strength low opening pressure stent design |
US8568471B2 (en) | 2010-01-30 | 2013-10-29 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds |
US8808353B2 (en) | 2010-01-30 | 2014-08-19 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds having a low crossing profile |
WO2011097098A1 (en) * | 2010-02-03 | 2011-08-11 | Boston Scientific Scimed, Inc. | A therapeutic balloon with systemic drug loss protection and controlled particle size release |
US8398916B2 (en) * | 2010-03-04 | 2013-03-19 | Icon Medical Corp. | Method for forming a tubular medical device |
CA2794064A1 (en) | 2010-03-24 | 2011-09-29 | Advanced Bifurcation Systems, Inc. | Methods and systems for treating a bifurcation with provisional side branch stenting |
CA2794078A1 (en) | 2010-03-24 | 2011-09-29 | Advanced Bifurcation Systems, Inc. | Stent alignment during treatment of a bifurcation |
EP2549952A4 (en) | 2010-03-24 | 2017-01-04 | Advanced Bifurcation Systems, Inc. | System and methods for treating a bifurcation |
US8389041B2 (en) | 2010-06-17 | 2013-03-05 | Abbott Cardiovascular Systems, Inc. | Systems and methods for rotating and coating an implantable device |
JP5902165B2 (en) * | 2010-08-02 | 2016-04-13 | コーディス・コーポレイションCordis Corporation | Flexible spiral stent with different spiral regions |
US10406009B2 (en) | 2010-09-15 | 2019-09-10 | Abbott Cardiovascular Systems Inc. | Bioabsorbable superficial femoral stent patterns with designed to break links |
US8507088B2 (en) * | 2011-01-04 | 2013-08-13 | Eastman Kodak Company | Porous particles with multiple markers |
US8507089B2 (en) * | 2011-01-04 | 2013-08-13 | Eastman Kodak Company | Articles with porous particles for security purposes |
CA2826760A1 (en) | 2011-02-08 | 2012-08-16 | Advanced Bifurcation Systems, Inc. | Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use |
EP3449879B1 (en) | 2011-02-08 | 2020-09-23 | Advanced Bifurcation Systems Inc. | System for treating a bifurcation with a fully crimped stent |
US9585780B2 (en) | 2011-02-25 | 2017-03-07 | Abbott Cardiovascular Systems Inc. | Pressure chamber and apparatus for loading material into a stent strut |
US20120216908A1 (en) | 2011-02-25 | 2012-08-30 | Abbott Cardiovascular Systems Inc. | Methods Of Drug Loading A Hollow Stent By Immersion |
US8936827B2 (en) | 2011-02-25 | 2015-01-20 | Abbott Cardiovascular Systems Inc. | Methods of loading a hollow stent with a drug or drug formulation |
US8927047B2 (en) | 2011-02-25 | 2015-01-06 | Abbott Cardiovascular Systems Inc. | Methods of drug loading a hollow stent with a high viscosity formulation |
US8757219B2 (en) | 2011-02-25 | 2014-06-24 | Abbott Cardiovascular Systems Inc. | Suction pump and apparatus for loading material into a stent strut |
US8733408B2 (en) | 2011-02-25 | 2014-05-27 | Abbott Cardiovascular Systems Inc. | Cover sleeve and apparatus for loading material into a stent strut |
US9238514B2 (en) | 2011-02-25 | 2016-01-19 | Abbott Cardiovascular Systems Inc. | Vacuum chamber and apparatus for loading material into a stent strut |
CA2839526A1 (en) | 2011-06-23 | 2012-12-27 | Dsm Ip Assets B.V. | Micro- or nanoparticles comprising a biodegradable polyesteramide copolymer for use in the delivery of bioactive agents |
US9873765B2 (en) | 2011-06-23 | 2018-01-23 | Dsm Ip Assets, B.V. | Biodegradable polyesteramide copolymers for drug delivery |
US8726483B2 (en) | 2011-07-29 | 2014-05-20 | Abbott Cardiovascular Systems Inc. | Methods for uniform crimping and deployment of a polymer scaffold |
US8992595B2 (en) | 2012-04-04 | 2015-03-31 | Trivascular, Inc. | Durable stent graft with tapered struts and stable delivery methods and devices |
US9254212B2 (en) | 2012-04-06 | 2016-02-09 | Abbott Cardiovascular Systems Inc. | Segmented scaffolds and delivery thereof for peripheral applications |
US9498363B2 (en) | 2012-04-06 | 2016-11-22 | Trivascular, Inc. | Delivery catheter for endovascular device |
MX351261B (en) | 2012-06-01 | 2017-10-06 | Surmodics Inc | Apparatus and method for coating balloon catheters. |
US9827401B2 (en) | 2012-06-01 | 2017-11-28 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US11090468B2 (en) | 2012-10-25 | 2021-08-17 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
PL2961350T3 (en) | 2013-02-27 | 2018-07-31 | Spirox, Inc. | Nasal implants and systems |
WO2014182542A1 (en) | 2013-05-06 | 2014-11-13 | Abbott Cardiovascular Systems Inc. | A hollow stent filled with a therapeutic agent formulation |
BR112016030273A2 (en) | 2014-06-24 | 2017-08-22 | Icon Medical Corp | MEDICAL DEVICE AND METHOD FOR FORMING SAID DEVICE |
WO2016033196A1 (en) | 2014-08-26 | 2016-03-03 | Spirox, Inc. | Nasal implants and systems and method of use |
SG10201902499VA (en) | 2014-09-03 | 2019-04-29 | Genesegues Inc | Therapeutic nanoparticles and related compositions, methods and systems |
CA2969171C (en) | 2014-12-18 | 2023-12-12 | Dsm Ip Assets B.V. | Drug delivery system for delivery of acid sensitive drugs |
US9999527B2 (en) | 2015-02-11 | 2018-06-19 | Abbott Cardiovascular Systems Inc. | Scaffolds having radiopaque markers |
US9700443B2 (en) | 2015-06-12 | 2017-07-11 | Abbott Cardiovascular Systems Inc. | Methods for attaching a radiopaque marker to a scaffold |
US20180200185A1 (en) | 2015-07-23 | 2018-07-19 | Novaflux, Inc | Implants and constructs including hollow fibers |
CN113349985A (en) | 2015-09-25 | 2021-09-07 | 斯贝洛克斯公司 | Nasal implants and systems and methods of use |
US11766506B2 (en) | 2016-03-04 | 2023-09-26 | Mirus Llc | Stent device for spinal fusion |
JP6934889B2 (en) | 2016-05-02 | 2021-09-15 | エンテラス メディカル インコーポレイテッドEntellus Medical,Inc. | Nasal flap implant and its transplant method |
US11006944B2 (en) | 2017-07-07 | 2021-05-18 | Arthrex, Inc. | Surgical device and methods of delivering implants |
WO2020112816A1 (en) | 2018-11-29 | 2020-06-04 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US11819590B2 (en) | 2019-05-13 | 2023-11-21 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5306286A (en) * | 1987-06-25 | 1994-04-26 | Duke University | Absorbable stent |
US5769884A (en) * | 1996-06-27 | 1998-06-23 | Cordis Corporation | Controlled porosity endovascular implant |
US5980564A (en) * | 1997-08-01 | 1999-11-09 | Schneider (Usa) Inc. | Bioabsorbable implantable endoprosthesis with reservoir |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5132080A (en) * | 1944-11-28 | 1992-07-21 | Inco Limited | Production of articles from powdered metals |
US4101984A (en) * | 1975-05-09 | 1978-07-25 | Macgregor David C | Cardiovascular prosthetic devices and implants with porous systems |
US4073999A (en) * | 1975-05-09 | 1978-02-14 | Minnesota Mining And Manufacturing Company | Porous ceramic or metallic coatings and articles |
US4082893A (en) * | 1975-12-24 | 1978-04-04 | Sumitomo Electric Industries, Ltd. | Porous polytetrafluoroethylene tubings and process of producing them |
US4208745A (en) * | 1976-01-21 | 1980-06-24 | Sumitomo Electric Industries, Ltd. | Vascular prostheses composed of polytetrafluoroethylene and process for their production |
US4222977A (en) * | 1978-05-16 | 1980-09-16 | Monsanto Company | Process to produce inorganic hollow fibers |
US4405319A (en) * | 1980-04-08 | 1983-09-20 | Renal Systems, Inc. | Porous titanium coating for blood access device |
DE3067421D1 (en) | 1980-05-21 | 1984-05-17 | Sfec | Process for the production of a dry inorganic ultrafiltration membrane and membrane produced by such a method |
DE3019996A1 (en) * | 1980-05-24 | 1981-12-03 | Institute für Textil- und Faserforschung Stuttgart, 7410 Reutlingen | HOHLORGAN |
SE452404B (en) * | 1984-02-03 | 1987-11-30 | Medinvent Sa | MULTILAYER PROTEST MATERIAL AND PROCEDURE FOR ITS MANUFACTURING |
US4784160A (en) * | 1986-08-19 | 1988-11-15 | Cordis Corporation | Implantable device having plasma sprayed ceramic porous surface |
US4784159A (en) * | 1986-08-19 | 1988-11-15 | Cordis Corporation | Process for making an implantable device having plasma sprayed metallic porous surface |
US5226913A (en) * | 1988-09-01 | 1993-07-13 | Corvita Corporation | Method of making a radially expandable prosthesis |
US5019090A (en) * | 1988-09-01 | 1991-05-28 | Corvita Corporation | Radially expandable endoprosthesis and the like |
US5163958A (en) * | 1989-02-02 | 1992-11-17 | Cordis Corporation | Carbon coated tubular endoprosthesis |
WO1990013332A1 (en) * | 1989-05-11 | 1990-11-15 | Cedars-Sinai Medical Center | Stent with sustained drug delivery |
IT1230047B (en) * | 1989-07-04 | 1991-09-27 | Giovanni Brotzu | VASCULAR PROSTHESIS CONTAINING IN THE WALL INGLOBAN MICROCAPS HORMONE-PRODUCING CELLS. |
US5176617A (en) * | 1989-12-11 | 1993-01-05 | Medical Innovative Technologies R & D Limited Partnership | Use of a stent with the capability to inhibit malignant growth in a vessel such as a biliary duct |
US5059166A (en) * | 1989-12-11 | 1991-10-22 | Medical Innovative Technologies R & D Limited Partnership | Intra-arterial stent with the capability to inhibit intimal hyperplasia |
EP0528993A1 (en) * | 1990-05-18 | 1993-03-03 | STACK, Richard S. | Intraluminal stent |
FR2663217B1 (en) * | 1990-06-15 | 1992-10-16 | Antheor | FILTERING DEVICE FOR THE PREVENTION OF EMBOLIES. |
US5222971A (en) * | 1990-10-09 | 1993-06-29 | Scimed Life Systems, Inc. | Temporary stent and methods for use and manufacture |
US5116360A (en) * | 1990-12-27 | 1992-05-26 | Corvita Corporation | Mesh composite graft |
US5411550A (en) * | 1991-09-16 | 1995-05-02 | Atrium Medical Corporation | Implantable prosthetic device for the delivery of a bioactive material |
US5903815A (en) * | 1992-02-12 | 1999-05-11 | Icm/Krebsoge | Composite powdered metal component |
CA2117379C (en) * | 1992-02-14 | 1999-11-16 | Kypriacos A. Athanasiou | Multi-phase bioerodible implant/carrier and method of manufacturing and using same |
US5383928A (en) * | 1992-06-10 | 1995-01-24 | Emory University | Stent sheath for local drug delivery |
US5449382A (en) * | 1992-11-04 | 1995-09-12 | Dayton; Michael P. | Minimally invasive bioactivated endoprosthesis for vessel repair |
US5342348A (en) * | 1992-12-04 | 1994-08-30 | Kaplan Aaron V | Method and device for treating and enlarging body lumens |
US5453235A (en) * | 1993-01-29 | 1995-09-26 | Impra, Inc. | Method of forming dual porosity FTFE tubes by extrusion of concentric preforms |
US5618298A (en) * | 1993-10-23 | 1997-04-08 | Simon; Michael | Vascular prosthesis made of resorbable material |
CA2193983C (en) * | 1994-06-27 | 2005-07-26 | William M. Colone | Radially expandable polytetrafluoroethylene and expandable endovascular stents formed therewith |
US5480711A (en) * | 1994-07-12 | 1996-01-02 | Ruefer; Bruce G. | Nano-porous PTFE biomaterial |
US5891108A (en) * | 1994-09-12 | 1999-04-06 | Cordis Corporation | Drug delivery stent |
IT1274098B (en) | 1994-11-08 | 1997-07-15 | Xtrode Srl | CORONARY ENDOPROTESIS |
US5707385A (en) * | 1994-11-16 | 1998-01-13 | Advanced Cardiovascular Systems, Inc. | Drug loaded elastic membrane and method for delivery |
CA2163824C (en) | 1994-11-28 | 2000-06-20 | Richard J. Saunders | Method and apparatus for direct laser cutting of metal stents |
US6124523A (en) * | 1995-03-10 | 2000-09-26 | Impra, Inc. | Encapsulated stent |
ATE223180T1 (en) * | 1995-04-19 | 2002-09-15 | Schneider Usa Inc | COATED DILATATOR FOR DELIVERY OF A MEDICINAL MEDICINE |
US5503795A (en) * | 1995-04-25 | 1996-04-02 | Pennsylvania Pressed Metals, Inc. | Preform compaction powdered metal process |
US5895406A (en) | 1996-01-26 | 1999-04-20 | Cordis Corporation | Axially flexible stent |
US5713949A (en) * | 1996-08-06 | 1998-02-03 | Jayaraman; Swaminathan | Microporous covered stents and method of coating |
US5928279A (en) * | 1996-07-03 | 1999-07-27 | Baxter International Inc. | Stented, radially expandable, tubular PTFE grafts |
US5807404A (en) | 1996-09-19 | 1998-09-15 | Medinol Ltd. | Stent with variable features to optimize support and method of making such stent |
IL131063A (en) * | 1997-01-24 | 2005-07-25 | Kentucky Oil N V | Bistable spring construction for a stent and other medical apparatus |
US5817126A (en) * | 1997-03-17 | 1998-10-06 | Surface Genesis, Inc. | Compound stent |
US5843172A (en) * | 1997-04-15 | 1998-12-01 | Advanced Cardiovascular Systems, Inc. | Porous medicated stent |
US5855600A (en) * | 1997-08-01 | 1999-01-05 | Inflow Dynamics Inc. | Flexible implantable stent with composite design |
US5972027A (en) | 1997-09-30 | 1999-10-26 | Scimed Life Systems, Inc | Porous stent drug delivery system |
-
1997
- 1997-09-30 US US08/940,696 patent/US5972027A/en not_active Expired - Lifetime
-
1998
- 1998-09-04 WO PCT/US1998/018343 patent/WO1999016386A1/en active Application Filing
-
1999
- 1999-10-18 US US09/420,094 patent/US6253443B1/en not_active Expired - Lifetime
-
2001
- 2001-06-13 US US09/880,615 patent/US20010029660A1/en not_active Abandoned
-
2008
- 2008-07-11 US US12/171,679 patent/US7963990B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5306286A (en) * | 1987-06-25 | 1994-04-26 | Duke University | Absorbable stent |
US5769884A (en) * | 1996-06-27 | 1998-06-23 | Cordis Corporation | Controlled porosity endovascular implant |
US5980564A (en) * | 1997-08-01 | 1999-11-09 | Schneider (Usa) Inc. | Bioabsorbable implantable endoprosthesis with reservoir |
Cited By (117)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7892221B2 (en) | 1996-07-02 | 2011-02-22 | Massachusetts Institute Of Technology | Method of controlled drug delivery from implant device |
US7918842B2 (en) | 1996-07-02 | 2011-04-05 | Massachusetts Institute Of Technology | Medical device with controlled reservoir opening |
US7901397B2 (en) | 1996-07-02 | 2011-03-08 | Massachusetts Institute Of Technology | Method for operating microchip reservoir device |
US8066763B2 (en) | 1998-04-11 | 2011-11-29 | Boston Scientific Scimed, Inc. | Drug-releasing stent with ceramic-containing layer |
US20040260391A1 (en) * | 1999-11-17 | 2004-12-23 | Santini John T. | Stent for controlled release of drug |
US7041130B2 (en) | 1999-11-17 | 2006-05-09 | Boston Scientific Scimed, Inc. | Stent for controlled release of drug |
US8236048B2 (en) | 2000-05-12 | 2012-08-07 | Cordis Corporation | Drug/drug delivery systems for the prevention and treatment of vascular disease |
US8303609B2 (en) | 2000-09-29 | 2012-11-06 | Cordis Corporation | Coated medical devices |
US8182527B2 (en) | 2001-05-07 | 2012-05-22 | Cordis Corporation | Heparin barrier coating for controlled drug release |
US8303643B2 (en) | 2001-06-27 | 2012-11-06 | Remon Medical Technologies Ltd. | Method and device for electrochemical formation of therapeutic species in vivo |
US20050186250A1 (en) * | 2001-09-19 | 2005-08-25 | Medlogics Device Corporation | Metallic structures incorporating bioactive materials and methods for creating the same |
US20030153536A1 (en) * | 2001-10-25 | 2003-08-14 | Mitchell Glass | Compounds and methods of treating transplant rejection |
US20030181520A1 (en) * | 2001-11-09 | 2003-09-25 | Mitchell Glass | Methods of reversing and preventing cardiovascular pathologies |
US8292945B2 (en) | 2001-11-30 | 2012-10-23 | Boston Scientific Scimed, Inc. | Stent designed for the delivery of therapeutic substance or other agents |
US20050278016A1 (en) * | 2001-11-30 | 2005-12-15 | Scimed Life Systems, Inc. | Stent designed for the delivery of therapeutic substance or other agents |
EP2255757A1 (en) * | 2001-11-30 | 2010-12-01 | Boston Scientific Limited | Stent designed for the delivery of therapeautic substance or other agents |
US20030181973A1 (en) * | 2002-03-20 | 2003-09-25 | Harvinder Sahota | Reduced restenosis drug containing stents |
US20050149163A1 (en) * | 2002-03-20 | 2005-07-07 | Harvinder Sahota | Reduced restenosis drug containing stents |
EP1348402A1 (en) * | 2002-03-29 | 2003-10-01 | Advanced Laser Applications Holding S.A. | Intraluminal endoprosthesis, radially expandable, perforated for drug delivery |
EP1348405A1 (en) * | 2002-03-29 | 2003-10-01 | Advanced Laser Applications Holding S.A. | Improved intraluminar perforated radially expandable drug delivery prosthesis |
US6960683B2 (en) | 2002-07-12 | 2005-11-01 | Atherogenics, Inc. | Salt forms of poorly soluble probucol esters and ethers |
US20040082807A1 (en) * | 2002-07-12 | 2004-04-29 | Meng Charles Q. | Novel salt forms of poorly soluble probucol esters and ethers |
US20060079713A1 (en) * | 2002-07-12 | 2006-04-13 | Atherogenics, Inc. | Novel salt forms of poorly soluble probucol esters and ethers |
US7371895B2 (en) | 2002-07-12 | 2008-05-13 | Atherogenics, Inc. | Salt forms of poorly soluble probucol esters and ethers |
US8920826B2 (en) | 2002-07-31 | 2014-12-30 | Boston Scientific Scimed, Inc. | Medical imaging reference devices |
US8281737B2 (en) | 2003-03-10 | 2012-10-09 | Boston Scientific Scimed, Inc. | Coated medical device and method for manufacturing the same |
US20050015142A1 (en) * | 2003-03-10 | 2005-01-20 | Michael Austin | Coated medical device and method for manufacturing the same |
US7288084B2 (en) | 2003-04-28 | 2007-10-30 | Boston Scientific Scimed, Inc. | Drug-loaded medical device |
US20040215169A1 (en) * | 2003-04-28 | 2004-10-28 | Scimed Life Systems, Inc. | Drug-loaded medical device |
US20080065201A1 (en) * | 2003-04-28 | 2008-03-13 | Boston Scientific Scimed, Inc. | Drug-loaded medical device |
US7468052B2 (en) | 2003-05-23 | 2008-12-23 | Brar Balbir S | Treatment of stenotic regions |
US7226473B2 (en) | 2003-05-23 | 2007-06-05 | Brar Balbir S | Treatment of stenotic regions |
US20070233173A1 (en) * | 2003-05-23 | 2007-10-04 | Brar Balbir S | Treatment of stenotic regions |
US20050187609A1 (en) * | 2003-05-23 | 2005-08-25 | Brar Balbir S. | Devices and methods for treatment of stenotic regions |
US20040236412A1 (en) * | 2003-05-23 | 2004-11-25 | Brar Balbir S. | Treatment of stenotic regions |
US20040236414A1 (en) * | 2003-05-23 | 2004-11-25 | Brar Balbir S. | Devices and methods for treatment of stenotic regions |
US6904658B2 (en) * | 2003-06-02 | 2005-06-14 | Electroformed Stents, Inc. | Process for forming a porous drug delivery layer |
US20040237282A1 (en) * | 2003-06-02 | 2004-12-02 | Hines Richard A. | Process for forming a porous drug delivery layer |
WO2004108346A1 (en) * | 2003-06-02 | 2004-12-16 | Electroformed Stents, Inc. | Process for forming a porous drug delivery layer |
US8377111B2 (en) | 2003-09-16 | 2013-02-19 | Boston Scientific Scimed, Inc. | Medical devices |
US7488343B2 (en) | 2003-09-16 | 2009-02-10 | Boston Scientific Scimed, Inc. | Medical devices |
US20050060021A1 (en) * | 2003-09-16 | 2005-03-17 | O'brien Barry | Medical devices |
US20050119723A1 (en) * | 2003-11-28 | 2005-06-02 | Medlogics Device Corporation | Medical device with porous surface containing bioerodable bioactive composites and related methods |
US20060085062A1 (en) * | 2003-11-28 | 2006-04-20 | Medlogics Device Corporation | Implantable stent with endothelialization factor |
US20060115512A1 (en) * | 2003-11-28 | 2006-06-01 | Medlogics Device Corporation | Metallic structures incorporating bioactive materials and methods for creating the same |
WO2005053766A1 (en) * | 2003-11-28 | 2005-06-16 | Medlogics Device Corporation | Medical device with porous surface containing bioerodable bioactive composites |
US8137397B2 (en) * | 2004-02-26 | 2012-03-20 | Boston Scientific Scimed, Inc. | Medical devices |
WO2005091834A2 (en) | 2004-03-09 | 2005-10-06 | Boston Scientific Limited | Coated medical device and method for manufacturing the same |
US8739727B2 (en) | 2004-03-09 | 2014-06-03 | Boston Scientific Scimed, Inc. | Coated medical device and method for manufacturing the same |
EP1737377A2 (en) * | 2004-03-09 | 2007-01-03 | Boston Scientific Limited | Coated medical device and method for manufacturing the same |
EP1737377A4 (en) * | 2004-03-09 | 2009-12-02 | Boston Scient Ltd | Coated medical device and method for manufacturing the same |
EP1576936A1 (en) * | 2004-03-16 | 2005-09-21 | Admedes Schuessler GmbH | Stent with a strut structure |
US20060085059A1 (en) * | 2004-03-16 | 2006-04-20 | Michael Ehrlinspiel | Stent having a bridge structure |
US8858616B2 (en) | 2004-03-16 | 2014-10-14 | Admedes Schuessler Gmbh | Stent having a bridge structure |
US20110014264A1 (en) * | 2004-12-09 | 2011-01-20 | Boston Scientific Scimed, Inc. | Medical Devices Having Nanostructured Regions For Controlled Tissue Biocompatibility And Drug Delivery |
US20070073385A1 (en) * | 2005-09-20 | 2007-03-29 | Cook Incorporated | Eluting, implantable medical device |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US8574615B2 (en) | 2006-03-24 | 2013-11-05 | Boston Scientific Scimed, Inc. | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8187620B2 (en) | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
US8771343B2 (en) | 2006-06-29 | 2014-07-08 | Boston Scientific Scimed, Inc. | Medical devices with selective titanium oxide coatings |
US20080058919A1 (en) * | 2006-08-01 | 2008-03-06 | Kramer-Brown Pamela A | Composite polymeric and metallic stent with radiopacity |
US9265866B2 (en) | 2006-08-01 | 2016-02-23 | Abbott Cardiovascular Systems Inc. | Composite polymeric and metallic stent with radiopacity |
US8052743B2 (en) | 2006-08-02 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
US8353949B2 (en) | 2006-09-14 | 2013-01-15 | Boston Scientific Scimed, Inc. | Medical devices with drug-eluting coating |
US8057534B2 (en) | 2006-09-15 | 2011-11-15 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8128689B2 (en) | 2006-09-15 | 2012-03-06 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis with biostable inorganic layers |
US8808726B2 (en) | 2006-09-15 | 2014-08-19 | Boston Scientific Scimed. Inc. | Bioerodible endoprostheses and methods of making the same |
WO2008034007A2 (en) * | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Medical devices |
US7955382B2 (en) | 2006-09-15 | 2011-06-07 | Boston Scientific Scimed, Inc. | Endoprosthesis with adjustable surface features |
US8052744B2 (en) | 2006-09-15 | 2011-11-08 | Boston Scientific Scimed, Inc. | Medical devices and methods of making the same |
WO2008034007A3 (en) * | 2006-09-15 | 2008-05-15 | Boston Scient Scimed Inc | Medical devices |
US8002821B2 (en) | 2006-09-18 | 2011-08-23 | Boston Scientific Scimed, Inc. | Bioerodible metallic ENDOPROSTHESES |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
US8080055B2 (en) | 2006-12-28 | 2011-12-20 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8715339B2 (en) | 2006-12-28 | 2014-05-06 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8431149B2 (en) | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
US8070797B2 (en) | 2007-03-01 | 2011-12-06 | Boston Scientific Scimed, Inc. | Medical device with a porous surface for delivery of a therapeutic agent |
US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
US7976915B2 (en) | 2007-05-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Endoprosthesis with select ceramic morphology |
US8002823B2 (en) | 2007-07-11 | 2011-08-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US7942926B2 (en) | 2007-07-11 | 2011-05-17 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8205317B2 (en) * | 2007-07-16 | 2012-06-26 | Medtronic Vascular, Inc. | Method of manufacturing a controlled porosity stent |
US20090024199A1 (en) * | 2007-07-16 | 2009-01-22 | Medtronic Vascular, Inc. | Controlled Porosity Stent |
US9284409B2 (en) | 2007-07-19 | 2016-03-15 | Boston Scientific Scimed, Inc. | Endoprosthesis having a non-fouling surface |
US7931683B2 (en) | 2007-07-27 | 2011-04-26 | Boston Scientific Scimed, Inc. | Articles having ceramic coated surfaces |
US8815273B2 (en) | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
US8221822B2 (en) | 2007-07-31 | 2012-07-17 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
US8900292B2 (en) | 2007-08-03 | 2014-12-02 | Boston Scientific Scimed, Inc. | Coating for medical device having increased surface area |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US7938855B2 (en) | 2007-11-02 | 2011-05-10 | Boston Scientific Scimed, Inc. | Deformable underlayer for stent |
US8029554B2 (en) | 2007-11-02 | 2011-10-04 | Boston Scientific Scimed, Inc. | Stent with embedded material |
US7833266B2 (en) * | 2007-11-28 | 2010-11-16 | Boston Scientific Scimed, Inc. | Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment |
WO2009070447A1 (en) * | 2007-11-28 | 2009-06-04 | Boston Scientific Scimed, Inc. | Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment |
US8252048B2 (en) | 2008-03-19 | 2012-08-28 | Boston Scientific Scimed, Inc. | Drug eluting stent and method of making the same |
US20110166646A1 (en) * | 2008-03-19 | 2011-07-07 | Boston Scientific Scimed, Inc. | Drug Eluting Stent and Method of Making the Same |
US8187322B2 (en) | 2008-03-19 | 2012-05-29 | Boston Scientific Scimed, Inc. | Drug eluting stent and method of making the same |
US20090240324A1 (en) * | 2008-03-19 | 2009-09-24 | Boston Scientific Scimed, Inc. | Drug Eluting Stent and Method of Making the Same |
US8920491B2 (en) | 2008-04-22 | 2014-12-30 | Boston Scientific Scimed, Inc. | Medical devices having a coating of inorganic material |
US8932346B2 (en) | 2008-04-24 | 2015-01-13 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8449603B2 (en) | 2008-06-18 | 2013-05-28 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US20100082096A1 (en) * | 2008-09-30 | 2010-04-01 | Boston Scientific Scimed, Inc. | Tailored Luminal & Abluminal Drug Elution |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
US8231980B2 (en) | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
US8267992B2 (en) | 2009-03-02 | 2012-09-18 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US8071156B2 (en) | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8287937B2 (en) | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
US8668732B2 (en) | 2010-03-23 | 2014-03-11 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
US11096774B2 (en) | 2016-12-09 | 2021-08-24 | Zenflow, Inc. | Systems, devices, and methods for the accurate deployment of an implant in the prostatic urethra |
US11903859B1 (en) | 2016-12-09 | 2024-02-20 | Zenflow, Inc. | Methods for deployment of an implant |
US11890213B2 (en) | 2019-11-19 | 2024-02-06 | Zenflow, Inc. | Systems, devices, and methods for the accurate deployment and imaging of an implant in the prostatic urethra |
Also Published As
Publication number | Publication date |
---|---|
US20080288059A1 (en) | 2008-11-20 |
US5972027A (en) | 1999-10-26 |
US6253443B1 (en) | 2001-07-03 |
US7963990B2 (en) | 2011-06-21 |
WO1999016386A1 (en) | 1999-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6253443B1 (en) | Method of forming a stent | |
US6723120B2 (en) | Medicated porous metal prosthesis | |
EP1527754B1 (en) | Porous medicated stent | |
EP2555811B1 (en) | Endoprosthesis | |
EP0956056B1 (en) | Multilayer liquid absorption and deformation devices | |
US20060276879A1 (en) | Medical devices having porous layers and methods for making the same | |
US20080131479A1 (en) | Endoprosthesis with three-dimensional disintegration control | |
WO2001041678A2 (en) | Open-celled microcellular polymeric foams for use as vascular grafts and stent covers | |
EP1981578A2 (en) | Biodegradable device | |
JP2010503489A (en) | Biodegradable endoprosthesis and method for producing the same | |
CA2465517C (en) | Drug eluting radially expandable tubular stented grafts | |
EP2124817A2 (en) | Bioabsorbable coatings for medical devices | |
US10085859B2 (en) | Methods of manufacturing a drug-eluting stent | |
US20080071344A1 (en) | Medical device with porous surface | |
MXPA98002936A (en) | Porosa medicated endoprotesis and method of | |
MXPA98002937A (en) | Method for making a porosomedic metal protesis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018505/0868 Effective date: 20050101 Owner name: BOSTON SCIENTIFIC SCIMED, INC.,MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018505/0868 Effective date: 20050101 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |